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Abstract 
The preparation and evaluation of a number of carboxylic acid protecting 
groups is reported. The preparation of aspartic acid side chain esters of 9- 
anthracenylmethanol, 1 -(9'-anthracenyl)-3-methylbutan-3-ol, 1 -(4'-fluorophenyl)-2- 
4ke 
methylpropan-2-ol, dibenzosuberol and 4-methyl-2,6,7-tiioxqbicyclo[2.2.2]oct \j I - 
C'C cMSCt\btd. 
The conversion of these into suitably protected NaFmoc derivatives for the 
solid phase synthesis of peptides has been carried out and the comparison with 
established protection strategies is discussed. 
Model compounds of these derivatives have been prepared which have 
enabled an evaluation to be carried out of the stability of these systems to acidic and 
basic hydrolysis. 
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Acm t.iometh$ 
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DIC N, N'-diisopropylcarbodiimide 
DMAP 4-N, N-dimethylaminopyridine 
DMF N, N-dimethylformamide 
FAB fast atom bombardment 
Fmoc 9-fluorenylmethoxycarbonyl 
HOBt 1-hydroxy-1, 2, 3-benzoiriazole 
HOCt 1-hydroxy-4-ethoxycarbonyl-1, 2, 3-triazole 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrometry 
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m multiplet 
NMR nuclear magnetic resonance spectroscopy 
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Pmc 2, 2, 5,7, 8-pentamethylchroman-6-sulphonyl 
s singlet 
t triplet 
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CHAPTER 1: INTRODUCTION 
1.1 SOLID PHASE PEPTIDE SYNTHESIS 
• 	Solid phase peptide synthesis was introduced in 1963 by Merrifield' who 
developed this innovative methodology to overcome the problems associated with 
the synthesis of high molecular weight peptides in solution. 
Peptide synthesis in solution is burdened by the need for isolation and 
purification at every chemical step. The rate of the acylation coupling reactions can 
often be very slow consequently making the syntheses very time-consuming and 
labour intensive. Also the larger the peptide becomes the greater the problems 
encountered in its solubility in organic solvents such as dichioromethane and DMF. 
These are the problems that were addressed and overcome by Merrifield's 
procedure. This is generally summarised in scheme 1. The original idea of solid 
phase synthesis has been subject to a number of modifications. The original Boc 2 
based methodology (Merrifield) is complemented by the Fmoc modified protocol as 
exemplified by scheme 2. 
Because the synthesis is executed on an insoluble polymeric support the 
solubility problems are largely circumvented. Use of an excess of the acylating agent 
can enhance the coupling efficiency and maximise the yield. All the purification is 
carried out upon completion of the synthetic cycle, negating the need for 
recrystallisation after every step. 
Finally the automation of solid phase peptide synthesis has contributed 
greatly to its current widespread application. This has made rapid synthesis of very 
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N} 	co 	CO2H 
Scheme 1: Merrifield solid phase peptide synthesis. 
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Scheme 2: Fmoc modified solid phase peptide synthesis 
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1.1.1 The insoluble support 
Merrifield's pioneering synthesis was carried out using a styrene-
divinylbenzene copolymer which once chloromethylated could be functionalised 
with the first amino acid in the peptide sequence by esterification. It has been 
generally accepted that copolymerisation of styrene with 0.5-2% divinylbenzene 
results in the best physical properties. This firstly will allow swelling during 
solvation to occur and secondly maintain rigidity and insolubility thus allowing 
facile filtration. The swelling is necessary to facilitate the access of reactants and to 
maximise the useful physical space for the growing peptide chain. 
1.1.2 The peptide-resin linkage 
The peptide is attached to the polymer by esterification through a linker 
moiety. With the Merrifield resin (1) this can be achieved by reaction of the caesium 
salt of the protected amino acid with the alkyl halide. Alternatively the Wang 3 (p-
benzyloxybenzyl alcohol) resin (2) contains a hydroxyl terminus and can be 
esterified with the symmetrical anhydride of the amino acid. This may be prepared 
using diisopropylcarbodiimide and DMAP (0.2 mol equivalent) and can be 
facilitated by sonication. This resin (4) possesses a degree of acid lability towards 
TFA that makes it particularly suitable for use in conjunction with Fmoc protection. 








There has been prodigious effort expended in the development of novel 
linkers in solid phase chemistry and these have allowed the synthesis of peptide 
amideS4 . 5 and peptide hydrazides. The compounds (3) and (5) are examples of 
linkers capable of producing peptide amides. 
Alternative linkers have also given rise to a choice of reaction conditions for 
the construction of peptide acids. Thus the very acid labile \2'-k re..s° has been 
applied in Fmoc chemistry and has found use in the preparation of protected 
fragments because its lability exceeds that of the side chain protecting groups. 
However significant losses were observed when it was used in conjunction with 
HOBt, which although being only slightly acidic is used repeatedly. 
x 
C P 0 Polymer 
(3), X=NH2; (4), X=OH 
CH3 	x 
CH3O" 	 0 Polymer 
(5), X=NH2; (6), X=OH 
The phenylacetamidomethyl (PAM) resin6' 7  has found application in the 
scheme using Boc chemistry. Premature loss of peptide from the resin when the 
Merrifield resin shown in Scheme 1 was used resulted in the need for a more acid 
stable support. The PAM linker (7) achieves this due to the inductive effect of the 
electron withdrawing group -CH2CONH-. 
	
HO 
.----_ 	 Polymer 
(7) 
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1.1.3 The requirement for protection in peptide synthesis 
Selective protection of the reactive functional groups present in amino acids 
must be employed to achieve the preparation of the desired compound. Without this 
a number of possible couplings may occur, some of which are described in Figure 1 
where R 1 and R2 are simple alkyl groups. 
The C-terminal amino acid requires protection of its carboxylate function and 
this is usually achieved by eterification. A variety of groups have been devised for 
this purpose including benzyl, pheny1 8 and trity19 esters. In the solid phase method 
protection is accomplished by esterification to the solid support. 
Reversible protection of the Naamino group of the acylating component is 
mandatory. The Naprotecting group must be amenable to quantitative removal 
under mild conditions that leave the other functional groups unaffected, especially 
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Figure 1: Peptide formation without protecting groups 
rol 
1.1.4 Protecting group strategies in peptide chemistry: Temporary a-amino 
protection 
The first generally successful reversible amine protecting group for peptide 
synthesis was the benzyloxycarbonyl (Z) group (8) developed by Bergmann and 
Zervas'° 
 
This group is rapidly cleaved by catalytic hydrogenolysis under neutral conditions at 
room temperature. It can also be removed by acidolysis using HBr in acetic acid 
when hydrogenolysis proves inappropriate. 
Although Merrifield initiated his studies using benzyloxycarbonyl protection 
this was soon to be replaced by the tertiary-butoxycarbonyl (Boc) group" (9) the 





Application of Boc (9) protection of the amino function allowed the use of milder 
conditions for the repeated acid deprotection steps involved and reduced the 
premature loss of unfmished peptide from the support. This protecting group can be 
cleaved using TFA in dichioromethane and can be selectively removed in the 
presence of benzyl based protection. This ease of acid lability is due to the stability 
of the tertiary butyl cation and this led to the development of even more acid labile 
protecting groups (Figure 2). The 2-(4'-biphenyl)propyl-2-oxycarbonyl (10), 2- 
7 
phenylpropyl-2-oxycarbonyl (11), 2-(3',5 '-dimethoxyphenyl)propyl-2-oxycarbonyl 
(12) and trimethyiphenyl (trityl) (13) protecting groups have subsequently been 
developed 12 based upon closely related stabilised cations. 
CH3 
0— CO— 'D+ Co - CH3 	 CH3 
	
(10) 	 (11) 





(12) 	 (13) 
Figure 2: Some examples of very acid labile Naprotecting groups 
The protecting group Bpoc (10) was found to be cleaved 3000 times more rapidly 
than Boc 12. In some of the above examples however the extreme sensitivity to acid 
causes them to be too unstable for most practical uses. 
When one of these very acid labile Na  protecting groups (e.g. Boc or Bpoc) 
is employed they are compatible with benzyl based side chain protection. In this 
protocol a graded acidolysis deprotection procedure is employed where the amine 
protection can be removed by relatively mild acid (e.g. TFA) and the side chain 
protecting groups and the peptide-resin linkage are cleaved with HBr in TFA or HF 
alone. 
However, because such a procedure is not perfect and because some peptide 
sequences are peculiarly acid sensitive, the base labile fluorenylmethoxycarbonyl 
(Fmoc) protecting group (14) of Carpino13 14  has been adopted widely as N 
protecting group in solid phase peptide synthesis. In combination with acid labile 
8 
side chain protection Fmoc provides a clearly defined orthogonality. The Fmoc 
group can be removed using a secondary amine such as piperidine or morpholine. It 
has also been shown that piperidine and pyrrolidine can bring about complete 




The proton at the 9 position is readily abstracted to form the fluorenyl anion 
which benefits from aromatic stabilisation. This is followed by elimination to the 
alkene in an Elcb mechanism releasing a carbamic acid which spontaneously 




g< H + RNHCO2 
+ Co2 
Scheme 3: The deprotection of Fmoc Naprotection 
The base lability of this protecting group makes it ideal for use in conjunction with 
acid labile side chain protection eliminating any of the losses experienced under 
conditions of graded acidolysis. Subsequently other base labile protecting groups 
such as the 2, 2-bis(4'-nitrophenyl)ethoxycarbonyl (Bnpeoc) (15) group 15 have been 
introduced. Using this strategy the peptide products do not experience strongly acid 





Many amino acids are polyfunctional and require protection at their side 
chains during the assembly of the polypeptide. These are generally referred to as 
permanent protecting groups. In Fmoc peptide chemistry the most common side 
chain protecting groups are acid labile and are often tertiary butyl based 16 . 
AMINO ACID PROTECTING GROUP REFERENCE 
Asp/Glu tertiary butyl ester 17,18 
Arg Pmc 19 
His Trityl 20 
Cys Acm! StBu 21,22 
Ser/Thr/Tyr tertiary butyl ether 23 
Lys Boc 24 
Table 1: Commonly used side chain protecting groups in Fmoc chemistry 
1.1.5 Peptide bond formation 
Coupling of amino acids is realized in practice by the activation of one 
carboxylic acid to attack by the amine of the next amino acid. A great variety of 
synthetic methods have been applied to the synthesis of amide bonds. 
Dicyclohexylcarbodiimide25 has most frequently been exploited for the 
synthesis of peptide bonds in which an 0-acyl urea intermediate is the agent 
10 
responsible for the acylation to give the peptide and the urea as the by-product 
(Scheme 4), which can be removed from the resin by washing with methanol. The 
urea derived from diisopropylcarbocliimide is more readily soluble in 
dichloromethane therefore DIC is often preferred for solid phase peptide synthesis. 
aNCN 	RCO2H R  No- 	0 4 
N 
__O 
R 	 + 
H \-/ 
Scheme 4: Amide bond formation via DCC 
If the activated species is not attacked by a nucleophile sufficiently quickly it 
may spontaneously rearrange to the N-acyl urea compound (Figure 3). These species 
are completely inert and the reaction is irreversible. 
	
R--/<o NH--O 	0 NH---O 
04 	




Figure 3: N-acylurea formation 
Addition of DMAP, a powerful acylation catalyst, prevents this side 
reaction from occurring. It reacts very rapidly with the 0-acyl urea resulting in 
formation of the activated intermediate (16) which can be attacked by the amino 
11 
component resulting in peptide bond formation. 
R_( NH_-Q 
o (N Q 
DMAP 
R 	 CH3 
(16) 
Preparation of acid anhydrides is a rapid and effective method for the 
activation of carboxylic acids. Mixed anhydrides 27 can be derived from the acid and 
the corresponding alkyl chloroformate but they have two possible carbonyl groups 
activated to nucleophilic attack. This results in a decrease of the chemical specificity 
unless great care is exercised in the choice of anhydride used. 
0 0 	 0 	 0 
RO' 	
R"NH2 	 + )~ IIIYMIIR 	NHR 	O  
The very hindered pivalic anhydride 28 can be used to direct attack at the 
desired carbonyl while phosphinic anhydrides such as diphenylph.osh'anhydride 29 
provide complete selectivity as the phosphorus centre is not attacked. 
R)LOJ ,7( 0 0 II 	II 
RO 2 
Alternatively symmetrical anhydrides have been frequently employed but 
these are wasteful because only half of the reagent is transferred. This can be very 
costly when expensive protected intermediates are involved. Symmetrical anhydrides 
can be prepared by reaction of the appropriate amino acid with 0.5 equivalents of 
carbodiimide. DCC may be used for this purpose but it is often found to be expedient 








Active esters do not suffer from the same drawbacks as anhydrides and can 
often be prepared in a stable form30' 31  for use in automated synthesis or, 
alternatively, may be prepared in situ from the acid, hydroxy component and the 
carbodiimide. This approach generally inhibits rearrangement to the N-acyl urea. N-
hydroxysuccinimide (18), pentafluorophenol (19) and N-hydroxybenzotriazole (20) 
represent some of the most utilised examples of this type possessing a range of 
reactivity towards aminolysis. 
O 	 OH 
N0H O(N 
O 	 F 	 OH 
(18) 	 (19) 	 (20) 
Classically acid azides 32 have been employed for the synthesis of peptides but 
they have not been adopted in automated solid phase synthesis. Azides are generally 
efficient acylating agents but require low reaction temperatures for their use in order 
to prevent rearrangements to isocyanates and subsequent urea formation. 
Carpino has proposed that Fmoc amino acid chlorides 33 be extended to solid 
phase peptide synthesis. Their tendency to form oxazolones (21) in the presence of 




Their application in conjunction with tertiary butyl based side-chain protection has 
been unsuccessful, due to traces of HCI that are inevitably present. 
To overcome this limitation Fmoc amino acid fluorides 35 can be used for the 
direct amination in the presence of an amine base without oxazolone formation. 
They can be prepared from the Fmoc amino acid and cyanuric fluoride to yield 
crystalline derivatives. 
F 
OANL.(OH 	) .iL 
0 R 	
NN 





Scheme 5: The preparation of an Fmoc amino acid fluoride 
These intermediates are compatible with Boc and tertiary butyl protected 
intermediates and are not prone to racemisation. They are stable under aqueous 
conditions and do not react well with neutral oxygen nucleophiles in contrast to acid 
chlorides, however they are unsuitable intermediates for the preparation of active 
esters. 
14 
Upon completion of an activation/coupling cycle in solid phase peptide 
synthesis, before deprotection of the Ne-terminal Fmoc group is effected an efficient 
"capping" of any unreacted amine from the previous residue is required in order to 
prevent the formation of deletion peptides. This can be done by acetylation using a 
solution of acetic anhydride, diisopropylethylamine, and N-hydroxybenzotriazole 36 . 
1.1.6 Déprotection of Fmoc 
The deprotection of Fmoc using 20% piperidine in DMF leads to the 
formation of an adduct between the dibenzofulvene produced and the base, this has 
also been observed with morpholine. 
QO HO 0cC 
Figure 4: The formation of 9-piperidinylmethyifluorene 
This gives rise to a UV spectrum with a maximum at 302 nm 37. At this point 
the extinction coefficient of residual fulvene in the mixture is relatively low and the 
measurement of the spectrum at this wavelength can be used to calculate the 
efficiency of deprotection and give an indication of the coupling efficiency. Such a 
monitoring system has been employed in this laboratory. 
The extension of the monitoring to the coupling steps to provide immediate 
feedback, and thus control of the synthesis, has recently been realised through the 
use of the triazole (23) 1-hythoxy-4-ehoxycarbony1-1,2,3-triazole (HOCt) for the 




Substituting the fused phenyl ring of HOBt with an ethyl ester group simplifies the 
UV spectrum of the active ester (24) formed between this triazole and an Fmoc 
amino acid. 
0 




The ultra violet spectrum of the active ester is measured at 302 nm before and after 
the coupling step. This is compared to a solution of a standard (fluorene) to deduce 
the amount of Fmoc ester which has been incorporated 38. This can be used to provide 
immediate information and offers the opportunity for recoupling of the residue 
before deprotection is carried out and it is too late. 
1.1.7 Final deprotection 
Upon completion of the synthesis, acid catalysed solvolysis is used to liberate 
the peptide from the resin and remove the side chain protecting groups. This can be 
effected by the action of 95% aqueous TFA together with the appropriate 
scavengers. An alternative hard acid deprotection 39 has been proposed by using 
16 
bromotrimethylsilane in TFA and reducing the contact time to around 20 minutes. 
The bromotrimethylsilane when dissolved in TFA is a source of hard acid, the silyl 
group acting as a surrogate for the proton of HBr. In studies using Boc chemistry 
where benzyl ester protection of the side chain of aspartic acid is favoured this 
procedure was found to minimise the acid catalysed cyclisation to aspartimide 
peptides. 
1.2 SIDE REACTIONS IN PEPTIDE SYNTHESIS 40 
1.2.1 Unprotected carboxyl function 
The -carboxyl of aspartic acid requires to be protected during the assembly 
of the peptide. In the absence of protection during activation the aspartyl 3-
carboxylate can behave as a nucleophile resulting in complications 41 . Thus during 
activation by anhydride or active ester the unprotected 3-carboxylic acid may 
combine with the activating reagent resulting in the activation of the 3-aspartyl 
carboxylic acid to nucleophilic attack. 
x 	 0 
j








X = Activating species (e.g. ester or anhydride) 
Figure 5: Side reactions in unprotected aspartyl peptides 
This activated species (Figure 5) may react with another peptide chain on the 
17 
resin to cause branching or it can be attacked by the adjacent amide nitrogen to give 
the cyclic imide. The cyclisation to aspartimide peptides is an ongoing problem in 
solid phase peptide synthesis. However aspartimide formation is not only a problem 
observed in synthesis. The pH-dependant cycisation 42 of unprotected aspartyl 
peptides has been reported to occur during storage in aqueous solution. The 
phenomenon is aggravated at low pH. 
1.2.2 Protected carboxyl function 
The protection of aspartic acid as a carboxylic ester is not without problems. 
Cyclisation to aspartimide peptides has been observed in a number of protected 
examples and can occur by either acidic (Figure 6) or basic catalysis (Figure 7), 
conditions. that are prevalent throughout solid phase peptide synthesis methodology. 
In Boc chemistry repeated TFA/triethylamine (or DIEA) treatment is used to remove 
semi-permanent amine protection and regenerate the free amine. In Fmoc solid phase 
peptide synthesis piperidine is used for Fmoc deprotection and TFA is employed for 
final deprotection and liberation of the peptide from the resin. 
OR 
4  (Lo  
0H R 
OR 
H 	 (o-H o 
0H R 




o H R 0H R 
(17) 
Figure 6: Acid catalysed aspartimide formation 
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OR 	 OR 
Base 	 0 	0 
N 
0H R 	 R 
0 
~—NH4H R 
Figure 7: Base catalysed aspartimide formation 
1.23 The chemistry of the aspartimide peptide 
Upon formation of this cyclic imide the peptide may then be subject to 
nucleophilic attack and consequently ring opening. Alkaline hydrolysis e.g. sodium 
hydroxide43  will result in the regeneration of the peptide but ring opening to the f-
peptide prevails under these conditions. Prolonged exposure to piperidine or 
pyrrolidine, conditions that prevail in Fmoc chemistiy ring opening occurs '. The 
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Figure 8: Products resulting from nucleophilic attack upon the aspartimide ring 
In the aspartimide ring racemisation of the aspartyl residue may occur when 
exposed to nucleophilic bases 46. Studies carried out on aspartyl-phenylalanine amide 
sequences have revealed the presence of an epimerised mixture of a and [3 aspartyl 
peptides resulting from the action of piperidine on the aspartimide compound (25). 
Boc 
(25) 
The formation of aspartimide compounds in peptide synthesis is particularly 
prevalent when glycine47  is the residue adjacent to the aspartic acid. Cyclisation has 
been observed in aspartyl-serine 48  sequences when serine has not been protected. The 
mechanism has been rationalised by intramolecular catalysis involving base 
cs4rc c,tto" 
promoted removal of the serine hydroxyl proton followed byjof the proton from the 












Figure 9: Aspartimide formation in aspartyl-serine peptides 
The cyclic nature of the intermediate was deduced from the results of the 


















ZNH 	 L OH  
OH 
Figure 10: The formation of isomeric asparagine peptides 
When histidine5 ' is the amino acid following the aspartyl residue a similar 
intramolecular catalysis brought about by the histidine imidazole has been reported. 
21 
Aspartyl-isoleucine and aspartyl-valine are relatively unaffected presumably due to 
steric hindrance. 
Asparagine derivatives are also known to undergo a to f rearrangement 
under basic conditions via a cyclic imide intermediate 52. The structure (17) may 
therefore be derived from peptides possessing an asparaginyl-glycine bond. These 
derivatives can be cydised under wealdy alkaline conditions 53 to give the 
succinimide (aspartimide) peptide and ammonia. This reaction was responsible for 
the erroneous structure determination of porcine ACTH. The chemical synthesis by 
Schwyzer and Sieber54  of this 39 amino acid hormone led to the correction of this 
error. Asparagine replaced the aspartate residue and the glutamine was replaced by a 
glutamic acid in the correct sequence 55 . 
1.3 PROTECTING GROUPS FOR ASPARTIC ACID 
Benzyl esters were the first to be applied to 13 aspartyl protection and still find 
favour in Boc chemistry. Tertiary butyl esters 16 are used throughout Fmoc 
methodology and both protecting groups possess shortcomings. Repeated application 
of acid during Boc based peptide synthesis causes cyclisation to occur with the 
expulsion of benzyl alcohol. The tertiary butyl ester although regarded as stable to 
nucleophiles does not totally suppress aspartimide formation 56. The instability of this 
group to hydroxide has been noted 57. This group is still the most commonly used 
aspartate protecting group particularly in Fmoc chemistry. When difficult sequences 
are involved this is not acceptable 58 . 59 .  
With Boc Na protection in solid phase peptide synthesis cyclohexyl esters 60 
(28) have been employed. This has been shown to suppress the formation of 
aspartimide during HF cleavage of peptides. During exposure to triethylamine it was 
shown to give 14% imide after 24 hours, this was compared to benzyl ester 
- 	22 
protection which produced 100% cyclic compound under the same conditions. This 
Would appear to make the cyclohexyl ester unsuitable for Fmoc synthesis. 
Furthermore the studies of Pedroso et a156  showed that upon treatment with 20% 
piperidine in DMF that the cyclohexyl ester gave 67% imide compared to 100% with 
benzyl and 11% when tertiary butyl protection was examined. This study also 





The use of phenacyl esters (28) has been applied to Boc chemistry with some 
success by Merrifield6 l.l may be deprotected using thiophenoxide prior to HF 
global deprotection. This technique led to the observation of 2.4% aspartimide upon 
cleavage attributed to acid catalysed ring closure acting upon the free carboxylate. 
Bodansky62  noted that the phenacyl group may actually have moderately activating 
properties as it could be described as a methyl ester possessing an electron 
withdrawing benzoyl substituent. This could then favour base catalysed nucleophilic 
attack leading to cyclisation. Its instability to nucleophiles as first noted would lead 
to reservations about its utility for the suppression of aspartimide formation under 
the basic conditions prevalent in Fmoc chemistry. 
The use of the ad.amanty1 63  esters (29) and (30) has also been examined with 
respect to aspartimide formation. Both of the isomers are acid labile to differing 
degrees. The 1-adamantyl (29) system based on a tertiary alkyl group can be 
removed in TFA but is resistant to 7M HC1 in dioxane. The 2-adamantyl (30) isomer 
can be cleaved rapidly by methanesuiphonic acid but is resistant to the conditions 
that cleave the 1-adamantyl ester. Both were shown to be resistant to basic 
conditions; aqueous sodium carbonate and 55% piperidine left both adamantyl esters 
23 
unaffected. No example of their use in Fmoc peptide chemistry has been reported but 
an examination64  of their compatibility with Boc protection has been evaluated. In 
studies on a model aspartyl-serine peptide between 0-3% of aspartimide was 





(29) 	 (30) 
In the development of silyl esters having improved stability over 
65 
trimethylsilyl the th-(+A-.- 	- j)\ esters (31) were prepared. The reagent used 
in their preparation is available from the reaction between trichlorosilane and tertiary 
butanol in the presence of pyridine and are easily incorporated into the side chain of 
aspartic acid. Despite their steric bulk they were found not to impede coupling 
reactions. They are cleaved almost instantaneously by 50% TFA but so far have not 
been applied to a synthesis involving an aspartimide sequence nor is any example 






1.4 REQUIREMENTS FOR A NOVEL PROTECTThIG GROUP 
The design of a novel protecting group for peptide synthesis is restricted by 
the need for compatibility with established procedures. Thus some of the points that 
require consideration are now discussed. 
1.4.1 Orthogonal deprotection 
An. orthogonal deprotection strategy is defined 66 as being one in which a set 
of independent classes of protecting group exist, where any one class of protecting 
group may be removed in any order in the presence of all the others without 
affecting them. 
Thus a novel side chain protecting group for use with Fmoc must be 
completely stable to attack by bases such as piperidine which are used throughout the 
synthetic cycle for the deprotection of Fmoc. Therefore an acid labile protecting 
group that will be rapidly deprotected by TFA compatible with existing side chain 
protection and resin cleavage is the objective. 
1.4.2 Steric hindrance 
In order to realise the goal of a derivative that will prevent the formation of 
aspartimide peptides a sterically hindered ester was sought. In carrying out this aim it 
has proved expedient to quantify the steric nature of the substrate by consideration of 
its degree of substitution. Following observations and experimental evidence 
reported by Newman 67  with regard to substitution reactions of carboxylic acids an 
empirical rule was proposed; 
"In reactions involving addition to an unsaturated function the greater the number of 
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The original numbering for acids has been modified to begin from the carbonyl 
carbon, the position of nucleophilic attack upon the ester. This rule of six was 
described by Longstafl 8 and can be best exemplified by the comparison of the 3-








R 0 CH2CH3 
CH2CH3 
Six number =0 Six number = 9 
The attempted application of this group to solid phase peptide synthesis was not 
possible due to its considerable acid lability. However it did exhibit an impressive 
resistance to basic hydrolysis as predicted by the rule of six. 
1.4.3 Monitoring 
In designing an improved protecting strategy the opportunity arises to to 
incorporate a physical label at the same time. A chemical tag that could easily be 
detected by simple physical or spectroscopic means would be desirable in order that 
the side reactions, which constitute the major problem in aspartic acid containing 
peptides, may be monitored. The simplest label would be one that was amenable to 
UV analysis which would allow in situ monitoring of chain assembly and 
deprotection stages to follow the course of the synthesis. 
1.4.4 By-products 
The problem of side reactions caused by the formation of activated cationic 
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species during deprotection is a frequently encountered problem in peptide synthesis. 
Alkylation of certain amino acid residues (e.g. Trp 69, Tyr7° and Met71) results from 
acidolysis. This has previously been addressed in the development of side chain 
protection strategies e.g in the cyclohexyl ester of Merrifield 60 whereby the 
secondary cyclohexyl cation was observed to undergo rearrangement to the relatively 
stable methylcyclopentyl cation. 
However it would be advantageous if the cation formed upon deprotection yielded a 
neutral species immediately upon cleavage. One of the products formed upon 
removal of the tertiary butyl based groups is isobutylene however it has been 
reported that tertiary butyl trifluoroacetate also produced upon cleavage can provide 
a reservoir of strongly alkylating tertiary butyl cations 72 . 
)z, 	'K + 40—COCF3  
1.4.5 Solubility 
The solubility of a novel derivative must come within the specifications of 
the synthetic protocol with respect to solid phase synthesis in order to avoid damage 
to the machine components. In addition increased concentration of reagents will 
improve the effectiveness of the reagent during the coupling steps. A solubility in 
DMF of 0.25 mol 11 is required for compatibility with the automated peptide 
synthesiser. 
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1.4.6 Economic viability 
It would be advantageous if the protecting group could be prepared simply 
from relatively inexpensive and readily available starting materials. The protecting 
group must be cleaved quantitatively upon completion of the synthesis to maximise 
the recovery of product. It is important that the incorporation of the group into an 
appropriate amino acid derivative- and its coupling during the assembly of a 
polypeptide are efficient in a field of chemistry where excesses of reagents are 
commonly used to effect close to quantitative yields. 
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CHAPTER 2: DISCUSSION 
2.1 STRATEGIES FOR THE PROTECTION OF ASPARTIC ACID 
When protecting the side chain functionality of an amino acid the initial 
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Figure 11: Options for the protection of aspartic acid 
Examples of specific esterification of the side chain of aspartic acid are limited to 
certain very well worked out examples whose experimental details are not usually 
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found to be generally applicable (for example; tertiary butyl 73, benzyl74 and 
cyclohexyl75 esters). 
Examples of suitably protected intermediates (Figure 11) include the N-
protected cyclic anhydride 76  (32) which can be directly esterified but a mixture of a 
and 13 isomers will usually be obtained (although the a isomer usually predominates 
as the a carboxyl is the more electrophilic position). Purification relies upon 
selective crystallisation of the appropriate amine salt 77 which will not always give 
satisfactory results especially with NXFmoc protection. 
The oxazolidinone derivatives, cleaved under hydrogenolytic conditions, 
offer a more reliable control of regiochemistry but they also have their drawbacks. 
The compound (35) can be prepared form the amino acid using hexafluoroacetone 78 
however this has not found popularity due to the difficulties involved with the 
handling of hexafluoroacetone. The attempted preparation of the oxazolidinone 
derivative79 (33) was unsuccessful under the conditions set out in Scheme 6 and was 
not pursued further. 
CO2H 








(a) parformaldehyde, acetic anhydride, thionyl chloride, acetic acid, 100°C, 4h. 
Scheme 6: Route to of 3-benzyloxycarbonyl-5-oxo-4-oxazolidineacetic acid 
The boroxazolidinone8° (34) offers an alternative to the above strategies as it 
is cleaved using anhydrous hydrogen chloride to regenerate the amino acid as its salt, 
however these conditions were thought to be too harsh for use in conjunction with 
acid sensitive derivatives. 
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The aspartic acid copper complex copper salt 8 ' (36) is easily prepared in 
almost quantitative yield, is exceedingly stable to prolonged storage and is easy to 
use. Its use has so far been limited to reaction with relatively simple, primary alkyl 
halides only. 
NI-I2 
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0 H 0 0'0"'~ax 
(41), X = NO2; (40), X = H. 
(a) benzylchloroformate, sodium hydrogen carbonate; (b) dicyclohexylamine, benzyl 
bromide or 4- nitrobenzyl bromide; (c) nitrosylsulphuric acid, glacial acetic acid; (d) 
cyclohexylamine; (e) potassium hydrogen sulphate. 
Scheme 7: The preparation of Nabenzyloxycarbonyl aspartic acid a benzyl ester 
Scheme 7 summarises a reliable, general protection of the a-amine and a-
acid functions of aspartic acid. The benzyloxycarbonylaspartic acid a-benzyl esters 
(40) and (41) can be prepared from asparagine by exploiting the amide of the amino 
acid as a protecting group for the 0 acid functionality. Benzyloxycarbonylasparagine 
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(38) was converted to its benzyl ester (39) by alkylating the ammonium salt with the 
appropriate halide. The amide can then be converted to a carboxylic acid by the 
action of nitrosylsuiphuric acid82 in glacial acetic acid. 
2.2 DIBENZOSUBERYL DERiVATIVES 
The alcohol dibenzosuberol (10,11 -dihydro-5H-dibenzo[a,d]cyclohepten-5-
01)83 (43) has been the subject of much interest since its synthesis in 1950. Pless 84 
carried out a study of the relative stabilities of the cations summarised in Figure 13 
and established the use of the dibenzosuberyl group as an acid-labile side chain 
protecting group for a number of amino acids. The dibenzosuberyl group was 
applied to the protection of the sulfhydryl group of cysteine, the hydroxyl group of 
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Figure 12: Dibenzosuberenyl and dibenzosuberyl protected asparagine derivatives 
The Fmoc and Bnpeoc derivatives of asparagine and glutamine protected by 
the dibenzosuberyl and dibenzosuberenyl groups have been synthesised for use in 
solid phase peptide synthesis 85. They have been evaluated in comparison with trityl 













Ka = [1] ft1201 I [ROH] [H] 
Figure 13: Stability of a series of related cations 84 
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2.2.1 The attempted preparation of aspartic acid 3-dibenzosuberyI ester 
















(a) DCC, DMAP, (40), CH202; (b) H2, Pd/C, methanol. 
Scheme 8: The attempted preparation of aspartic acid [-dibenzosuberyl ester 
The aim then was to extend this strategy to the side chain protection of 
aspartic acid through the preparation of Nafluorenylmethoxycarbonylaspartic acid-
3-dibenzosuberyl ester (50). The dibenzosuberyl moiety was successfully introduced 
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via DCCJDNlAP86 mediated coupling of the aspartate derivative (40) to the alcohol 
as shown in Scheme 8. Upon hydrogenolysis to remove the amine and a-carboxyl 
protecting groups none of the desired f-ester (45) could be detected. Instead aspartic 
acid and dibenzosuberane were obtained as a result of complete hydrogenolysis of 
the protecting groups. Closer inspection reveals that the C-5 position in the 
dibenzosuberyl ring may be regarded as a substituted benzylic derivative and this 
proved not to be resistant to catalytic hydrogenolysis. 
The aspartic acid copper complex (36) has been applied to the preparation of 
side chain esters using a number of primary alkyl halides but there is no reported 
example of its alkylation with a secondary alkyl halide. This was briefly examined 
but no reaction was observed between 5-chlorodibenzosuberane and the copper 
complex under literature conditions 81 . 
2.2.2 The attempted preparation of NLfluorenyImethoxycarbony1aspartic acid 
-dibenzosubery1 ester 
An alternative route to the target compound was devised (Scheme 9) utilising 
a base labile ester for temporary a-carboxyl protection. By using the commercially 
available starting material (46) differentiation between the a and P functionalities is 
already supplied. The phenyl ester of the derivative (46) was prepared by the method 
of Ramage87. This type of protecting group can be rapidly removed using dilute 
alkaline solution containing a catalytic quantity of hydrogen peroxide. The peroxide 
anion is an a-effect 88 nucleophile. The enhanced nucleophilicity of the peroxide 
anion is rationalised by the non-bonding electrons of the oxygen 
adjacent to the oxygen atom bearing the negative charge. The intermediate 
percarboxylic acid produced will be rapidly hydrolysed to the carboxylic acid 




























(a) DCC, pyridine, phenol; (b) TFA, CH202 (c) DCC, DMAP, (43),(d) sodium 
hydroxide, hydrogen peroxide, water. 
Scheme 9: The attempted preparation of Nafluorenylmethoxycarbonylaspartic acid 
-3-dibenzosuberyl ester 
The tertiary butyl ester was smoothly removed in trifluoroacetic acid to give 
the a-protected carboxylic acid (48). This was esterified using dibenzosuberol and 
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Se\ec+- 
DCCIDMAP. Unfortunately and surprising1y,hydro1ysis of the phenyl ester could 
not be achieved. TLC indicated that a mixture of products was produced and upon 
aqueous work up no single product could be isolated. TLC and NIMR evidence 
indicated that significant competitive hydrolysis of the dibenzosuberyl ester was 
occurring under these conditions. 
2.2.3 Stability Studies 
This observed instability to base had not been reported previously. A 
comparative study of the base lability of the acetate esters of 4-nitrobenzyl alcohol 
(51) and dibenzosuberol (52) was carried out (Scheme 10). It was expedient to use 
the nitrobenzyl ester because the chemical shifts of the benzylic protons would allow 
differentiation between the product and starting material. In the alcohol the benzylic 
protons are found at 8H=4.8 and at H=5.2 in the corresponding ester. The base 









OH 	 OCOCH3 
(52) 
Scheme 10: The preparation of model acetate esters 
The hydrolysis of the respective esters was monitored by 1H NMR and 
quantified by inspection of the integrals. While it can be seen that the para-
nitrobenzyl ester (51) was much more labile the dibenzosuberyl acetate (52) was still 
hydrolysed at a significant rate. 
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Time(mm) 1 	1 30 	IF  120 
 100 - - 
 64 33 17 
Table 2: NMR study of ester hydrolysis 
Hydrocinnamate esters are useful as model compounds for protecting group 
stability studies in HPLC analysis. The dibenzosuberyl hydrocinnamate (53) was 
prepared via the acid chloride as shown by Scheme 11. 
OH 	 0?0 cr0 (a),(b) 	 0 
0 
(53) 
(a) oxalyl chloride; (b) pyridine, dichloromethane, dibenzosuberol. 
Scheme 11: The preparation of dibenzosuberyl hydrocinnam ate 
Aqueous alkaline hydrolysis was used as an indicator of the general stability 
of the compound to nucleophiles. The stability to alkali of this hydrocinnamate was 
studied by reverse phase HPLC. This showed that after 3 hours 50% hydrolysis had 
occurred which is consistent with the NMR results. 
2.2.4 Concluding remarks 
It has been shown that from synthetic and physical studies a number of 
structurally different dibenzosuberyl esters are relatively susceptible to hydrolysis by 
alkali. Their specific incorporation into the side-chain of aspartic acid proved 
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fruitless and the properties of the derivatives isolated were not encouraging. Thus it 
was concluded that these compounds would not satisfy the necessary criteria for an 
aspartic acid side chain protecting group. 
2.3 THE DERIVATIVES OF 1- (4 1 -FLUOROPHENYL) -2-METHYLPROPAN -2-OL 
This protecting group had originally been described by Longstaff 68, who 
applied it successfully to the synthesis of a pentapeptide Ile.Leu.Asp.Asn.Ile. 
Encouraged by the preliminary findings the protecting group was prepared in order 
that its use may be extended to the synthesis of a peptide that is susceptible to 
aspartimide formation. 
2.3.1 Synthesis of 1-(4'-fluorophenyl)-2-methylpropan-2-oI 
The methyl ester (55) can be obtained in high yield from 4-
fluorophenylacetic acid. Reaction of this with the Grignard reagent 
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F 	 F 
(54) 
	
(55) 	 (56) 
(a) methanol, concentrated sulphuric acid; (b) magnesium, iodomethane. 
Scheme 12: The preparation of 1-(4'-fluorophenyl)-2-methylpropan-2-ol 


















(a) (40), DCC, DMAP; (b) H2, Pd/C, methanol; (c) 9-fluorenylmethyl-succinimidyl 
carbonate, triethylamine. 
Scheme 13: Preparation of Na9fluorenylmethoxycarbonylaspartic acid-0-1-(4'- 
fluorophenyl)-2-methylprop-2-yl ester 
The alcohol (56) could be coupled to the protected acid (40) using 
DCC/DMAP (Scheme 13) to give the derivative (57) as a low melting solid after 
column chromatography. Catalytic hydrogenolysis gave the amino acid ester (58) 
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which was converted to the Fmoc protected compound (59) for use in solid phase 
peptide synthesis. 
The fluorophenyl ring was designed as a probe for use in analysing the 
aspartimide reaction by 19F NMR. The volume and the relative involatilityof DMF 
means the effluent cannot easily be analysed by NMR. A relatively small quantity of 
protecting group (56) was lost as a result of aspartimide formation making the NMR 
experiment too insensitive. It is not possible to distinguish between ring closure 
brought about by acid or base treatment through the use of a 19F NMR label. 
2.4 ANTHRACENYL DERIVATIVES 
'1' 
Monitoring of the synthesis by ultraviolet (UV)A  in a way similar to the 
system used during Fmoc deprotection would allow observation of the cyclisation in 
situ. The ultraviolet spectrum of the organic phase after acid cleavage can be used to 
determine the approximate quantity of UV tag that was still intact at this point. A 
suitable UV chromophore was required that would be distinct from the 
dibenzofulvene-piperidine adduct at 302 nm and sufficiently intense to provide a 
sensitive probe. 
The UV/visible spectrum of anthracene 89 (Figure 15) fulfilled these criteria 
and the ring could be functionalised without perturbing the chromophore. Typically 
anthracene has maximum wavelength values at 347, 365 and 385 nm and its 
extinction coefficient at 300 nm is approximately 500 dm 3mol 1cm 1 , while the 
extinction coefficient of the fulvene-piperidine adduct at 300 nm is 9200 dm 3mol 
1cm (i.e. it is about 5% of that of the adduct). 
The reactivity of the anthracene ring is towards electrophilic substitution at 
the 9 and 10 positions. Therefore although 1 and 2 substituted compounds are known 




5 	10 	4 
Figure 15: The numbering in the anthracene ring 
2.4.1 The esters of 9-anthracenylmethanol 
It has been demonstrated on a peptide containing an aspartyl-glycine 
sequence that benzyl ester protection of aspartic acid leads to the formation of the 
cyclic aspartimide compound. The anthracenylmethyl group can be regarded as a 
substituted benzyl group and possesses a chemical similarity, e.g rapid 
hydrogenolysis under catalytic conditions and similar sensitivity to basic hydrolysis. 
This group was studied as an a carboxyl protecting group in 1965 by Stewart9° and 
in 1973 Kornblum9 ' demonstrated that it was sensitive to nucleophiles such as 
mercaptans. It was intended that this system be used to demonstrate the practicability 
of the monitoring. 
2.4.2 The synthesis of Na9fluoreny1methoxycarbonyIaspartic acid--9-
anthracenylmethyl ester 
The anthracene derivative 9-chloromethylanthracene was required in large 
quantities and was prepared from the alcohol (60) and thionyl chloride at ambient 










CO2- 	-I Cu 
2 
I H\ /0 I 
(a) 	I Cu 













0A NH X OH 
0 	0. 
(64) 
(a) copper (II) acetate, water, (b) 9-chioromethylanthracene, tetramethylguanidine; 
(c) ethylenediamine tetraacetic acid disodium salt; (d) 9-fluorenylmethyl 
succcinimidyl carbonate, triethylainine. 
Scheme 14: The preparation of Naf1uoreny1methoxycarbony1aspartic acid--9- 
anthracenylmethyl ester 
Combination of the copper complex (36), aspartic acid and 
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tetramethylguanidine in the ratio of 1:2:4 provided the copper aspartate complex 
tetramethylguanidinium salt 81 . One mole of the original complex (36) generates two 
moles of the aspartic acid copper complex tetramethylguanidinium salt as the copper 
displaced by the tertamethylguanidine is sequestered by the aspartic acid. The 
alkylation of this salt with 9-chioromethylanthracene could be achieved more 
efficiently than if the copper salt itself was used for the reaction. The product of this 
reaction was decomposed using the sodium salt of ethylenediaminetetraacetic acid, 
without intermediate purification, to obtain the amino acid ester (63) in a yield of 
40%. This compound proved difficult to reciystalise due to its very poor solubility 
characteristics. The incorporation 92 of the Fmoc amine protection proved inefficient 
presumably because of steric hindrance. Prolonged reaction times in this case are 
discouraged on account of the basicity of the reaction conditions, which may cause 
deprotection. Therefore, under these circumstances a yield of 42% of (64) was found 
to be acceptable for the purposes of this study (Scheme 14). 
2.4.3 The synthesis of 1-(9'-anthracenyl)-2-methylpropan-2-oI 
In order to model the tertiary butyl type of protecting group the compound 
(65) was prepared Initial attempts to use the Grignard reagent anthracenylmethyl 
magnesium chloride and combine it with acetone failed (Scheme 15). The Grignard 
reagent could not be prepared in either anhydrous THF or diethyl ether. 
(a), (b) > OH 




(a) magnesium, ether or THF; (b) acetone. 
Scheme 15: The attempted preparation of 1-(9'-anthracenyl)-2-methylpropan-2-ol 
44 
By taldng 9-bromoanthracene with n-butyllithium the aryl lithium 93 species 
could be formed and this reacted smoothly with isobutylene oxide with isolated 








(a) n-butyllithium, THF, -78°C; (b) isobutylene oxide. 
Scheme 16: The preparation of 1-(9'-anthracenyl)-2-methylpropan-2-ol 
2.4.4 The chemistry of 1-(9'-anthracenyl)-2-methylpropan-2-oI 
Initial studies of the esterification of the alcohol were centred around the 
established DCC/DMAP methodology in order to prepare (66) but this was 
unsuccessful. Repeated attempts with these reagents using different solvent 
conditions (DMF, dichloromethane and ethyl acetate) never provided any of the 
required product. Diisopropylcarbodiimide was used in place of the more sterically 





Tertiary esters can be prepared from the corresponding alkene under 
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conditions of acid catalysis'7. 18  Dehydration of the alcohol in TFA/dichloromethane 
gave a mixture of products that could not be purified. The alcohol (65) was 
converted to the alkene (66) by refluxing with 4-toluenesuiphonic acid to give the 
product shown in Scheme 17 as deduced from its NMR spectra. There was no 
reaction observed between this alkene and the compound (40) in the presence of 4-
toluenesuiphonic acid. 
e~<OH 
TsOH 	 •••% 
(67) 
Scheme 17: Dehydration of 1 -(9'-anthracenyl)-2-methylpropan-2-ol 
A number of small scale experiments followed by TLC were carried out to 
further probe the reactivity of the alcohol. These are described below. 
Oxalyl chloride was used to prepare the acid chloride of the aspartate 
compound (40) and this was characterised by the presence in the infrared of the 
bands at approximately 1790 cm 1 and the absence of absorptions between 2800-
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(68) 
(a) oxalyl chloride, reflux; (b) (65), base. 
Scheme 18: The attempted preparation of Nabenzyloxycarbonylaspartic acid-ct- 
beñzyl-- 1 -(9'-anthracenyl)-2-methylprop-2-yl ester 
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The alkoxide of the alcohol (65) was prepared using n-butyllithium or sodium 
hydride but none of the intended ester (66) could be detected upon addition of the 
acyl halide (68). 
Activating the acid as a mixed anhydride was attempted with isopropenyl 
chloroformate94 and triethylamine. This material (69) was used without 
characterisation in combination with the alcohol, triethylamine and DMAP. No 







(a) triethylamine, DMAP, isopropenyl chioroformate, THF; (b) (65). 
Scheme 19: The attempted preparation of NUbenzyloxycarbonylaspartic acid-a- 
benzyl-3- 1 -(9'-anthracenyl)-2-methylprop-2-yl ester .  
Tertiary alkyl bromides can be prepared by a number of methods. It was 
intended that the halide (70) could be prepared then combined with a suitable 
carboxylate salt to provide a tertiary ester. HBr in acetic acid containing 0.2 
equivalents of lithium bromide at OIC95  has been used to convert tertiary butyl 
alcohol to tertiary butyl bromide efficiently with high level of purity. The alcohol 
(65) could not however be converted to the bromide (70) under the conditions 
employed (Scheme 20). NMR and infrared speciroscopy indicated that the starting 
material remained unchanged. 
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OH 	(a) \/ 	 Br 
I 	 I A CrC 
(70) 
(a) 48% HBr, LiBr (0.75 eq.). 
Scheme 20: The attempted preparation of 1-(9'-anthracenyl)-2-methyl-2- 
bromopropane 
The reaction between trichioroimidates and carboxylic acids in the presence 
of boron trifluoride diethyl etherate 96 has been used in the preparation of tertiary 
esters. This was applied to this system but the preparation of the trichloroimidate 
(71) (Scheme 21) was not successful and the starting alcohol was recovered 
unchanged. 
NH 




(a) sodium hydride (0.1 eq.), dry ether, (b) trichioroacetonitrile, 60 minutes. 
Scheme 21: The attempted preparation of 1-(9'-anthracenyl)-2-methylprop-2-yl 
trichioroimidate 
The alcohol (65) could not be converted even to its acetate ester (Scheme 22) 
with pyridine and acetyl chloride. Extractive work up of portions over a period of 
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(72) 
Scheme 22: The attempted preparation of 1-(9'-anthracenyl)-2-methylprop-2-yl 
acetate 
Thus it was concluded that the steric hindrance caused by the protons at C-i 
and C-8 must be preventing interaction of the reagents 97 . 
2.4.5 The synthesis of 1-(9'-anthracenyl)-3-methylbutan-3-oI 
An attempt was made to relieve the steric hindrance caused by the H-i and 
H-8 protons by extension of the side chain. The derivative (77) was synthesised in 
order to overcome the problems due to steric hindrance. 
9-Chioromethylanthracene was combined with diethyl malonate and sodium 
hydride to give the product (73) as described in Scheme 23. The hydrolysis of the 
diethyl ester was achieved by both acid and base catalysed hydrolysis to provide 
quantities of the diacid (74). The yield with sodium hydroxide in aqueous acetone 
was superior and more reproducible than when concentrated hydrochloric acid in 
dioxane was used. The malonic acid derivative (74) proved to be thermally stable to 
a temperature of greater than 200°C. Simply heating to this temperature under an 
inert nitrogen atmosphere caused degradation of the molecule and no useful material 
was isolated. Using refluxing tetrahydronaphthalene (b.p. 207°C) the 
decarboxylation could be executed in 1.5 hours but with varying yields and 
unreliable recovery of acid. The methyl ester (76) was obtained from the acid 
catalysed esterification in methanol of the carboxylic acid (75) and was then 
combined with the Grignard reagent methyl magnesium iodide to give the alcohol 
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(77). This was accomplished in satisfactoiy yield and the products were obtained 





















(a) sodium hydride, diethyl malonate; (b) sodium hydroxide or hydrochloric acid; (c) 
tetrahydronaphthalene, reflux; (d) methanol, conc. sulphuric acid; (e) magnesium, 
iodomethane. 
Scheme 23: The preparation of 1-(9'-anthracenyl)-3-methylbutan-3-ol 
The preparation of the alcohol was simplified by replacing the malonic ester 
with the f3-keto ester (78). 13-Keto acids are in general less thermally stable than their 
analogous diacids 98 . 
The preparation of the 3-keto ester (78) from the reaction of 9-
chioromethylanthracene with tertiary butylacetoacetate (Scheme 24) and sodium 
hydride was carried out in THF at reflux since no reaction could be detected at room 
temperature. This compound. (78) was used without purification, its NMR indicating 
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that a high degree of conversion was obtained. The acid was obtained by the action 
of anhydrous TFA and was then decarboxylated in refluxing toluene. Purification of 
the ketone (79) over silica resulted in approximately 70% yield based on 9-
chloromethylanthracene. The Grignard reaction between methyl magnesium iodide 
and the ketone (79) to give the alcohol (77) was lower yielding than when the methyl 
ester (76) was the substrate (Scheme 23). Overall the second scheme proved simpler 












(a) sodium hydride, tertiary butylacetoacetate, (b) TFA, dichioromethane, (c) 
toluene, 110°C, (d) magnesium, iodomethane. 
Scheme 24: The preparation of 1-(9'-anthracenyl)-3-methylbutan-3-ol 
Further simplification of the synthesis of this compound (77) by preparation 
of the alkyne (81) was envisaged (Scheme 25). This could be reduced to the alcohol 
by catalytic hydrogenation. The palladium (0) catalysed coupling of 9-
bromoanthracene and 2-methylbut-3-yn-2-ol was carried out by analogy with the 











triphenylphosphine, palladium ( ) acetate, triethylamine, 2-methylbut-3-yn-2-ol 
hydrogen, Pd/C ( See Table 3). 
Scheme 25: The attempted preparation of 1-(9'-anthracenyl)-3-methylbutan-3-ol 
The compound (81) was identified by accurate mass spectrometry and by the 
presence of the hydroxyl in its infra-red spectrum. This was confirmed by the 
presence of an exchangeable proton at 1.8 ppm although the alkyne absorption could 
not be detected by infrared nor were the alkyne quaternary carbons observed in the 
NMR. 
Repeated attempts to reduce the triple bond through catalytic hydrogenation 
(10% palladium on charcoal) at ambient temperature and atmospheric pressure were 
unsuccessful. Increasing the pressure and varying the temperature (Table 3) did not 
provide the desired alcohol. TLC and 1.j  NMR evidence indicated that the 
compound (81) had decomposed. 
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solvent pressure temperature time 
methanol 3 atm ambient temp. 16 hours 
methanol/ethyl 3.5 atm 
acetate  
30°C 6 hours 
ethyl acetate 2 atm ambient temp. 4 hours 
rA tt€'-ç*e ci 
Table 3: Conditions for th(reduction of (81) 
2.4.6 The synthesis of Na9fluorenyImethoxycarbonyIaspartic acid-f3--1(9'-
anthracenyl)-3-methylbut-3-yI ester 
The efficient coupling of the alcohol (77) to the aspartyl derivative (40) was 
achieved by using an excess of the acid (40) because this acid was regarded as the 
more expendable component (Scheme 26). Additionally this acid could be removed 
by extraction with sodium carbonate or sodium hydrogen carbonate upon completion 
of the coupling. Acceptable yields of the ester were obtained using a threefold excess 
of acid (40) and dicyclohexylcarbodiimide (a 1:1 ratio of acid to carbodiimide was 
used to prevent the formation of the symmetrical anhydride). The crude ester was 
carried through to the hydrogenolysis stage because intermediate purification was 
impossible. The Rf of the ester and alcohol on TLC in a range of solvent systems 
was found to be almost identical hence a chromatographic separation were not 
feasible. An overall yield of side chain protected amino acid from these two steps of 
80%, with respect to the alcohol, was obtained after removal of the amine and a-
carboxyl protection by catalytic hydrogenation. Introduction of Fmoc using 
fluorenylmethylsuccinimidyl carbonate with triethylamine 92 was achieved with 
diminished yield relative to previous systems (e.g. 1-(4'-fluorophenyl)-2-




















(a) DCC, DMAP, (40), dichioromethane; (b) H2, Pd/C, THF/ methanol (3:7), (c) 9- 
fluorenylmethyl-succinimidyl carbonate, triethylamine. 
Scheme 26: Preparation of Nafluorenylmethoxycarbonylaspartic acid -1-(9'- 
anthracenyl)-3-methylbut-3-yl ester 
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2.4.7 Deprotection studies 
The fate of the cation (85) under conditions of peptide deprotection was 
investigated. 
(85) 
This species will be produced initially during acidolysis and it would be 
advantageous if it could scavenge itself decomposing to neutral non alkylating 
product. Because the side chains of some amino acids69' 70, 71 are sensitive to 
alkylation, scavengers such as ethanedithiol are used during final deblocking and 
resin cleavage. 
0  IPI I  ";k-. *~ ztt~ 8 
(86) 	 (87) 
It was hoped that the cation would be susceptible to intramolecular alkylation 
to form (86) thus rendering itself unreactive. The alcohol was stirred with 70% TFA 
and TLC showed that a mixture of products was formed. Similarly with 
toluenesuiphonic acid in refluxing toluene a complex mixture was observed. High 
resolution mass spectrometry found a peak for C 19H19 [i.e. (86) or (87)] but analysis 
of the 1H NMR spectrum indicated that a mixture of materials was present. HPLC 
analysis of the TFA cleavage of the hydrocinnamate ester (95) also resulted in the 
formation of a mixture of products. Further examination of these materials (e.g. by 
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GC/MS) was not undertaken. 
2.5 THE PREPARATION OF ORTHO ESTER DERIVATIVES 
The protection of the side chain of aspartic acid as an ortho ester'°° was also 
investigated. Their acid lability appeared to be quite within the specifications of the 
Fmoc peptide synthesis procedures and additionally it was thought probable that the 
products of acidolysis would be non-alkylating. The stability of these compounds to 
nucleophiles such as Grignard reagents seemed to indicate that they would be more 
than adequate for protection against intramolecular attack from an amide during 
assembly of a peptide. This type of protection has to date enjoyed limited application 
to amino acid chemistry, although their compatibility with urethane type protecting 
groups has been demonstrated'°'. 
CH2OH 













(a) potassium hydroxide, diethyl carbonate, (b) pyrolysis [220°C, 50 mmHg]. 
Scheme 27: The synthesis of 3-methyl-3-hydroxymethyloxetane 
3-Methyl-3-hydroxymethyloxetane (90) was prepared from the triol (88) via 



























(a) DCC, DMAP, 3-methyl hydroxymethyl oxetane ;(b) boron trifluoride diethyl 
etherate, triethylamine; (c) H 2, Pci/C, methanol; (d) 9-fluorenylmethyl-succinimidyl 
carbonate 






Esterification of (90) was achieved by carbodiimide coupling (Scheme 28) 
before the ester (91) was elaborated using the elegant Lewis acid-catalysed 
rearrangement of Corey 103. Upon cleavage of the temporary benzyl and 
benzyloxycarbonyl protection by hydrogenolysis the Fmoc protection was 
introduced as for the other amino acids using fluorenylmethylsuccinimidyl carbonate 
in dioxane to provide the derivative (94) for use in solid phase peptide synthesis. 
2.6 STABILITY STUDIES ON MODEL ESTERS 
2.6.1 Synthesis of 9-anthracenyl hydrocinnamate esters 
The two protecting groups based on the anthracenyl alcohols (60) and (77) 












(a) DCC, DMAP; (b) hydrocinnamic acid. 
Scheme 29: Preparation of model hydrocinnamate esters 
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The compounds (95) and (96) were obtained in satisfactory yield and were 
extensively purified by recrystallisation and column chromatography for the 
purposes of the HPLC study. 
2.6.2 	Synthesis 	of 
trioxabicyclo[2.2.2]octane 
The hydrocinnamate ester of the alcohol (90) was prepared using DCC and 
DMAP then converted to the ortho ester derivative (98) using the boron irifluoride 
Lewis acid catalysed rearrangement as described in Scheme 30. 









(a) DCC, DMAP, (90); (b) boron trifluoride cliethyl etherate, triethylamine. 
Scheme 30: The preparation of 	L3L —4--methyl 	 2,6,7- 
trioxabicyclo[2.2.2]octane 
After purification of (98) it was found that its storage at room temperature 
was not feasible as it was found to readily decompose. The hygroscopic nature of 
this derivative was surprising as the derivative (92) was stable at room temperature 
for several months Therefore the stability studies were carried Out using compound 
(92). 
2.6.3 Alkaline hydrolysis studies 
In the search for a protecting group that is orthogonal to Fmoc the stability to 
alkali of the hydrocinnamate derivatives was evaluated (Chapter 3.3), with the 
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exception of the example noted previously. This also provided an indication of the 
resistance of the ester towards nucleophilic attack.Thus the ease of hydrolysis 
exhibited by the 9-anthracenylmethyl and dibenzosuberyl esters indicated that they 
were inappropriate candidates for this purpose. 
The tertiary 1-(9'-anthracenyl)-3-methylbut-3-yl and 1-(4'-fluorophenyl)-2-
methylprop-2-yl esters have a pronounced stability to alkaline hydrolysis. The order 
of stability 1 -(9'-anthracenyl)-3-methylbut-3-yl greater than 1 -(4'-fluorophenyl)-2-
methylprop-2-yl greater than tertiary butyl was observed but none were as effective 
as the 3-ethylpent-3-yl group 68 . 
Hydrocinnamate Reaction time Degree of hydrolysis 
tertiary butyl68 24 hours 25% 
3-ethylpent-3-y1 68 4 days 0% 
benzy168 1 hour 100% 
1-(4'-fluorophenyl)-2- 
methylprop-2-y168  
5 days 25% 
dibenzosuberyl 3 hours 50% 
9-anthracenylmethyl 3 hours 55% 
1-(9'-anthracenyl)-3- 
methylbut-3-yl  
6 days 10% 
Table 4: Studies on the alkaline hydrolysis of some model esters 
MIC 
2.6.4 Acidolysis studies 
In conjunction with the stability to basic conditions a novel protecting group 
requires to be rapidly cleaved in the presence of TFA. Table 5 contains the data for 
the acidolysis in TFA for all the esters (Chapter 3.3). 
When the derivatives with poor base stability are eliminated from 
consideration the order of lability was found to be tertiary butyl greater than 1-(4-
fluorophenyl)-2-methylprop-2-yl greater than 1 -(9'-anthracenyl)-3-methylbut-3-yl. 
Hydrocinnamate Concentration 
TFA/dichloromethane 
Time for complete 
acidolysis 




3-ethylpent-3-y168 20% instantaneous 


















Table 5: Studies on the acidolysis of some model esters 
Only the 1-(9'-anthracenyl)-3-methylbut-3-yl group fails to meet this 
criterion as it has been shown to have a pronounced stability at concentrations of 
TFA that bring about instantaneous or nearly instantaneous cleavage of the other 
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examples. 
2.7 S0Lm PHASE PEPTIDE SYNTHESIS 
The hexapeptide Val.Lys.Asp.Gly.Tyr.Ile has been the subject of much 
investigation due to its pronounced tendency to undergo cyclic aspartimide 
formation. For this reason it has been adopted as a test peptide for the evaluation of a 
series of novel protecting groups. 
2.7.1 Synthesis of VaI.Lys.Asp.Gly.Tyr.Ile 
The peptide was prepared by the Fmoc Naprotecting strategy on an ABI 
automated peptide synthesiser using acid labile Wang resin and base labile Fmoc 
Naamine protection in conjunction with acid labile side chain protecting groups 
(Chapter 3.4) for the examination of the following protecting groups. The conditions 
used for Fmoc deprotection (20% (v/v) piperidine in DMF) and final acidolysis 
(aqueous TFA and scavengers) have been consistent throughout to enable 
comparisons to be made. 
2.7.2 Tertiary butyl ester protection 44 
- the use of NafluorenylmethoxycarbonyIaspartic acid n-tertiary butyl ester 
When the hexapeptide was synthesised with tertiary butyl side chain 
protection 13% aspartimide peptide was found. Only when piperidine was replaced 
by pyrrolidine for the deprotection of Fmoc was any ring opened compound 
observed. In this case it was the pyrrolidine amide compound. 
2.7.3 1-(4'-Fluorophenyl)-2-methylprop-2-yI ester protection 
- the use of Nafluoreny1methoxycarbony1aspartic acid 3-1-(4'-fluoropheny1)-2-
methylprop-2-yI ester 
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When this protecting group was used for the synthesis of the hexapeptide the 
results were comparable to the tertiary butyl group with respect to aspartimide 
formation. HPLC showed that the crude cleaved material contained 15% of the 
aspartimide compound. This was purified by preparative HPLC and characterised by 
high resolution FAB mass spectrometry and amino acid analysis. 
2.7.4 9-Anthracenylmethyl ester protection 
- the use of Nafluoreny1methoxycarbony1aSPartic acid 3-9-anthraceny1methyl 
ester 
A sample of 9-anthracenylmethanol in DMF was passed through the flow cell 
as a standard for calibration. From this it was found that as little as 1% loss of 
protecting group per deprotection cycle could be detected. The use of the 
anthracenylmethyl ester in the synthesis led to the isolation of the cyclisation product 
only. This was seen by detection of the deprotection eluent at 365 nm during the 
deprotection washes, by passing a diluted sample through an ultraviolet flow cell 
immediately after piperidine treatment. HPLC analysis was consistent with the U.V. 
observations and high resolution mass spectrometry confirmed that this was the 
aspartimide compound. It is clear from this that no ring opening is occurring under 
conditions of acid hydrolysis (i.e. upon liberation of the peptide from the resin and 
side chain deprotection). In this experiment no ring opened product (e.g. piperidine 
amide) was detected in contrast to other reports. Since there was no evidence of ring 
opening during acid or base treatment all the peptide isolated in subsequent 
experiments with the other protecting groups must have been the a isomer. 
2.7.5 1-(9'-Anthracenyl)-3-methylbut-3-yI ester protection 
- the use of Nafluorenylmethoxycarbonylaspartic acid 0-1-(9'-anthracenyl)-3-
methylbut-3-yl ester 
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Ultraviolet monitoring of the valine, lysine and aspartic acid deprotection 
cycles did not detect any material absorbing at 365 nm. This indicated that less than 
6% cyclisation occurred during the assembly of the sequence and that the protecting 
group appeared to be stable to the aminolysis by the amide of glycine under base 
catalysed conditions. 
However the peptide produced by TFA cleavage was analysed by HPLC and 
38.5% of the mixture was found to be aspartimide compound. The rate of acidolysis 
of this group in model studies is much slower than that for tertiary butyl and it would 
seem reasonable to assume that it is the persistance of the protonated intermediate 
(Figure 7, p  19) that allowed the cyclisation to occur. 
It was decided to examine the effect of using bromotrimethylsilane 
deprotection conditions. This resulted in diminution of the degree of aspartimide 
obtained. This may be due to the shorter deprotection time utilised in this technique 
rather than any change in the acidolysis mechanism. In this deprotection strategy 
75% peptide was obtained as opposed to 6 1.5% in the aqueous TFA cleavage. 
2.7.6 4-Methyl-2,6,7-trioxabicyclo[2.2.2]octane 
- the use of Na.fluoreny1methoxycarbony12.aminO3(4'-methYl-2',6,7')- 
trioxabicyclo[2.2.2]octylpropionic acid 
The evaluation of this protecting group in solid phase peptide synthesis was 
once more carried out upon the hexapeptide VaI.Lys.Asp.Gly.Tyr.Ile. Analytical 
HPLC of the cleaved peptide indicated the 100% formation of the aspartimide 
peptide, which was confirmed by high resolution mass spectrometry. 
The acid catalysed hydrolysis of ortho esters' 04• 	has been studied in some 
detail and is reported as being dependant upon rate determining addition of water to 
a carbocation formed rapidly in acidic solution. Therefore hydrolysis could be 
brought about as a result of the repetition of the steps described in Scheme 17. 
0~ 04 	0 ~ 04 	R+° 71 
HO 
10 
H +'H HO 
— — R--(—~~ 
Scheme 17: The mechanism for ortho ester hydrolysis 
As addition of water is rate determining for the hydrolysis then the 
competing nucleophilic attack bringing about ring closure may become problematic 
if it were sufficiently rapid. Therefore the formation of intermediates of the kind 
shown in Figure 17 may be responsible for cyclisation. 
HO OH 
HO 	 OH 
0~ 
Figure 17: Potential intermediates in the deprotection of an ortho ester protected 
peptide 
MAI 
protecting group % aspartimide % peptide 











Table 6: Observed proportion of peptide:aspartimide with respect to each protecting 
group 
2.7.7 Concluding remarks 
A comparative study has been carried out in which the relative utility for the 
protection of aspartic acid of a number of esters has been examined. 
The esters based upon the dibenzosuberyl group and the 9-anthracenylmethyl 
group are unstable to conditions of basic hydrolysis and experimental evidence in the 
example of the 9-anthracenylmethyl group has shown that it is unsuitable for Na 
Fmoc peptide synthesis and by analogy it is argued that this will also be true for the 
dibenzosuberyl group. 
The use of ortho ester protection is attractive because of the stated resistance 
to nucleophilic attack but examination of its application to the synthesis of a small 
peptide has shown that the sole product of the synthesis is the aspartimide peptide. It 
is reasonable to assume that this is a result of the acidolysis conditions. 
The sterically hindered tertiary esters based on the 1-(4'-fluorophenyl)-2- 
methylprop-2-yl and 1 -(9'-anthracenyl)-3-methylbut-3-Yl groups afford protection 
against the base catalysed intramolecular cyclisation and have potential for 
monitoring the progress of the synthesis. Unfortunately in the example of 1-(4'-
fluorophenyl)-2-methylprop-2-yl it has not been possible to confirm at which point 
cycisation occurs. 
From a consideration of the stability profiles of 1-(9'-anthracenyl)-3-
methylbut-3-yl group and 4-methyl-2,6,7-trioxabicyclo[2.2.2]octyl, group and UV 
analysis in the case of the former groups, the significance of the acid catalysed 
cyclisation cannot be overlooked and appears to play a major role in the tertiary 
hindered examples. 
Based upon observations on the 1 -(9'-anthracenyl)-3-methylbut-3-yl group 
this study has shown that steric hindrance obtained in a tertiary butyl like system 
appears to be the key to preventing base catalysed cyclisation during Fmoc 
deprotection. 
The combination of solid phase peptide synthesis, UV data on the 1-(9'-
anthracenyl)-3-methylbut-3-yl group and the alkaline hydrolysis data showed that 
tertiary esters are sufficiently hindered to prevent aspartimide formation during 
peptide synthesis. This suggests that it should be possible to design an acid labile 
protecting group that is sterically hindered for use in the protection of the aspartic 
acid side chain. 
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CHAPTER 3: EXPERIMENTAL 
3.1 NOTES 
Melting points were recorded in open capillaries on a BUchi 510 melting point 
apparatus and are quoted uncorrected. Optical rotations were measured in a 10 cm 
cell using a AA 1000 polarimeter (Optical Activity Ltd.). .Ultra-violet spectra were 
recorded on a Cary 210 spectrophotometer. Infra-red spectra were recorded on a 
Perkin-Elmer 281 or Bio-Rad FTS-7 (FT-IR) spectrophotometer. 1H NMR spectra 
were recorded on Bruker WP 80 (80 MHz), WP 200 (200 MHz) and WH 360 (360 
MHz) spectrometers with tetramethylsilane (TMS) as external standard (8H = 0.00). 
13C NMR spectra were recorded on BrUker WP 200 (50 MHz) and WH 360 (90 
M1-Iz) with TMS as external standard (c = 0.00). 19F NMR spectra were recorded 
on a Bruker WP 80 (75 MHz). Thin Layer Chromatography (TLC) was performed 
on aluminium sheets precoated with silica gel 60F254 in the following solvent 
systems; 
9/1, chloroform/methanol 
75/13/12, n-butanol/formic acid/water 
3/1/1, n-butanol/acetic acid/water 
15/10/6/3, n-butanoL/pyridine/water/acetic acid 
dichioromethane 
1/1, dichioromethane/ethyl acetate 
1/1, hexane/diethyl ether 
4/1, hexane/ethyl acetate 
and were visualised with UV at 254 nm, iodine, Mary's spray (4,4'-bis- 
[dimethylamino]-benzhydrol) for carboxylic acids, ninhydrin for amino acids and 
5% c.H2SO4/methanol followed by charring. Mass spectra were recorded on a 
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Kratos MS50TC. Elemental analyses were carried out on a Carlo Erba model 1106 
or Perkin-Elmer 2400 CHN elemental analyser. The following solvents were dried 
from the reagents given in parentheses, dichioromethane (calcium hydride), diethyl 
ether (sodium wire), tetrahydrofuran (sodium wire), ethyl acetate was distilled, DMF 
and dioxane were peptide synthesis grade (Rathburn Chemicals). Amino acids are 
unless otherwise stated of the L configuration and were purchased from the SAS 
group of companies and protected derivatives from Novabiochem. Amino acid 
analysis was carried out on LKB 4151A alpha plus amino acid analyser after 
hydrolysis in a sealed tube with constant boiling hydrochloric acid at 110°C for 20 
hours. Applied Biosystems equipment was used for HPLC (783A absorbance 
detector, 2 x 400 solvent delivery systems and a 1480A injection/mixer or 
equivalent) and eluted with water/0.1% TFA (solvent A) and acetonitrile/0.1% TFA 
(solvent B) using the gradients and columns described in the text. Detection of the 




Benzylchloroformate (50 ml, 0.35 mol) was added to a stirred solution of asparagine 
monohydrate (52.5 g, 0.35 mol) at 0°C in 1M sodium hydrogen carbonate (700 ml). 
After 24 hours, ensuring the solution was still alkaline, the excess benzyl 
chioroformate was removed by washing with diethyl ether. Upon acidification of the 
aqueous layer with concentrated hydrochloric acid the title compound (70 g, 75%) 
precipitated as a white solid which was dried in vacuo at 40°C, m.p. 165-167°C 
(lit. 106, 1630C); [cx]D22  ±8.0° (c 1.0, glacial acetic acid) (lit. 10, +9.6°); 
V x(nujo1)/cm' 3410 and 3340 (NH), 1700 (urethane CO), 1645 and 1525 (amide 
CO); H(200  MI-Iz, (CD3)2S0) 2.38-2.61 (21-1, m, PCHO, 4.31-4.39 (1H, m, cxCH), 
5.02 (211, s, benzylic CH2), 6.93 (111, br. m, NH), 7.35 (5H, s, aromatic CH). 
NaBen zvloxvcarbonviaaparagi ne benzvl ester (39 
N-Benzyloxycarbonylasparagine (70 g, 0.26 mol) was dissolved in DMIF (500 ml) 
containing dicyclohexylamine (48 ml, 0.24 mol) and warmed to 75°C then benzyl 
bromide (28 ml, 0.24 mol) was added. After 20 minutes the solution was filtered 
then poured into ice (1000 ml) and extracted with ethyl acetate (2 x 300 ml). The 
organic phase was washed with 1 M sodium hydrogen carbonate (500 ml), water (500 
ml), dried (MgSO4) and evaporated. The title compound (55 g, 59%) was obtained 
as a white solid from diethyl ether, m.p. 128-131°C (lit. 82, 131-132°C); [aID 22 -11.5 0 
(c 2.5, DMF), (lit. 82, - 12.90); H(80  MHz, (CD3)2S0) 2.63-2.68 (2H, m, 13CH2), 
4.35-4.62 (111, m, aCH), 5.03-5.11 (2 x 211, s, benzylic CH2), 7.33 (1011, s, 
aromatic CH), 7.70-7.80 (211, br. d, amide NH 2). 
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aspartic acid c—benzy1 ester cyclohexylammonium salt 
NaBenzyloxycarbonylasparagine benzyl ester (27.6 g, 77 mmol) was dissolved in 
glacial acetic acid (400 ml) and nitrosyl sulphuric acid (15g. 120 mmol) was added 
in 4 portions at intervals of several minutes while the temperature was maintained 
below 25°C. Ethyl acetate (100 ml) was added before heating at reflux to remove 
nitrogen oxides. The solvent was removed in vacuo and the residue poured into a 
large volume of water then extracted with ethyl. acetate (2 x 250 ml). The organic 
phase was washed with water (200 ml), brine (200 ml) and dried (MgSO 4). Upon 
removal of the solvent under reduced pressure cyclohexylamine (8.9 ml, 78 mmol) 
in diethyl ether (200 ml) was added and the cooled solution gave a precipitate of the 
title compound (23.3 g, 69%) which was filtered and washed copiously with ether, 
m.p. 118°C (lit.'°, 126°C). 
aspartic acid a-benzyl ester (40) 
NaBenzyloxycarbonyl aspartic acid ct-benzyl ester cyclohexylammonium salt (30 
g, 66 mmol) was partitioned between 2M potassium hydrogen sulphate (500 ml) and 
ethyl acetate (500 ml) then stirred for 2 hours. The organic phase was separated, the 
aqueous phase extracted with ethyl acetate (2 x 250 ml) then the combined organic 
solutions were washed with brine (500 ml) and dried (MgSO 4). Upon removal of the 
solvent in vacuo the solid obtained was recrystallised from ether/light petroleum(40-
60) to give title compound (15.15 g, 65%) as a white solid, m.p. 79-81°C (lit. 108 , 82-
83°C); [aID22  -11.40 (c 1.2, glacial acetic acid) (lit.'°, -93°C); TLC- (A) R f 0.4; 
vm (CH2Cl2)/cm4 3432 (NH), 1740 (ester CO), 1512 (amide II); H(200  MHz, 
CDC13) 2.92-3.06 (2H, m, 3CH2), 4.68-4.73 (1H, m, (tCH), 5.12 (211, s, benzylic 
CH2), 5.18 (2H, s, benzylic CH2), 5.93-5.98 (1H, br. d, NT-I), 7.32 (511, s, aromatic), 
7.34 (5H, s, aromatic). 
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N(XBenzv 1oxvcarbpny l..c benzyl[3..asparty l chloride (68) 
NaBenzyloxycarbonyl aspartic acid a-benzyl ester (180 mg, 0.5 mmol) was 
dissolved in oxalyl chloride (10 ml) then heated at reflux for 1 hour, until the 
evolution of gas ceased. This was then cooled and evaporated then evaporated three 
times from dry, distilled dichloromethane to give the title compound (200 mg) as an 
oil, vmax(CH2C12)/cm' 3423 (NH), 1789 (CO acyl halide), 1725 (CO ester), 1509 
(amide II). 
(X_Benzyloxycarbonyl aspartic acid--dibenzpsubervI-a-4-nitrobenzvl ester (44) 
To a solution of Nabenzyloxycarbonylaspartic acid-ct-4-nitrobenzyl ester (4 g, 10 
mmol) and dibenzosuberol (2.2 g, 10 mmol) were dissolved in distilled 
dichioromethane (30 ml) and stirred at 00  C. Dicyclohexylcarbodiimide (2 g, 10 
mmol) and a catalytic amount of DMAP were then added. After stirring for 3 days at 
room temperature the solution was filtered and evaporated. The crude material was 
dissolved in diethyl ether and washed with 10% sodium carbonate (lOOml), dried 
over magnesium sulphate and evaporated. A solid was obtained by trituration with 
ether/ëyclohexane then recrystallised from ethyl acetate/n-hexane to give the title 
compound (2.5 g, 42%) as an off-white solid, m.p. 113-114°C (Found: C, 68.4; H, 
5.2; N, 4.9. C34H30N208 requires C, 68.7; H, 5.2; N, 4.9%); [a]D22  +4.8 (c 1.0, 
CHC13); TLC- Rf (A) 0.82, R f (E) 0.5; vmax(CHC13)/cm4 3420 (NH), 1760 and 
1725 (CO), 1610 (aromatic), 1500 (amide CO); H(80  MHz, CDC13) 2.92-3.45 (6H, 
m, -CH2, Dbs CH2-CH2), 4.57-4.80 (1H, m, aCH), 5.07 (4H, s, 2 x benzylic CH2), 
5.53-5.75 (1H, br. d, NH), 6.86 (1H, s, 5CH Dbs), 7.11-7.38 (15H, m, aromatic CH), 
8.02 and 8.13 (2 x 1H, s, aromatic CH); c(50 MHz, CDC13) 31.75 (CH2, Dbs), 
36.21 (CH2), 49.98 (aCH), 65.17, 66.51 (benzylic CH2), 79.29 (5CH Dbs), 123.09, 
125.68, 127.51, 127.65, 127.98, 128.45, 129.02, 129.89 (aromatic CH), 135.62, 
139.48 (quaternary Dbs), 155.50, 169.27, 169.88 (CO quaternary); m/z (FAB) 595 
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(MH); HRMS: Found 595.20808. C 34 1-131 N208 requires 595.20802. 
NcL...9Fluorenylmethoxycarbonylaspartic acid-a-phenyl- 3-tertiary butyl ester (47) 
Na.9Fluorenylmethoxycarbonylaspartic acid-13-tertiary butyl ester (4.1 g, 0.01 mol) 
and phenol (0.94 g, 0.01 mol) were dissolved in distilled dichioromethane (50 ml) 
and cooled to 0°C. Dicyclohexylcarbodiimide (2.0 g, 0.Olmol) and two drops of 
pyridine were added. After stirring for 5 days at room temperature, the solution was 
filtered then evaporated and dissolved in ethyl acetate (100 ml), washed with sodium 
hydrogen carbonate (2 x 100 ml), citric acid (100 ml) and water (100 ml). The 
solution was dried (MgSO4) then evaporated to yield the title compound (3.48 g, 
72%) upon recrystallisation from ethanol, m.p. 133-136°C (Found: C, 70.9; H, 6.35; 
N, 3.3. C29H29N06 requires C, 71.4; H, 6.0; N, 2.9%); [a]0 22  +26.00 (c 0.5, 
CH202); TLC- Rf (E) 0.26, R f (F) 0.77; Xmax(MeOH)1u1m 291, 280 and 256 
(e/dm 3mol 1 cm' 5268, 2946 and 17411); v max (CH2C12)/cm' 3431 (NH), 3067 and 
2979 (CH), 1764 (ester CO), 1722 (urethane CO), 1593 (aromatic), 1510 (amide II); 
6H(200 MHz, CDCI3) 1.50 (91-1, s, C(CH3) 3), 2.82-3.18 (2H, m, CH2), 4.22-4.53 
(3H, m, Fmoc CH2, Fmoc 9-CH), 4.80-4.88 (1H, m, (xCH), 5.92 (1H, d, NH), 7.11- 
7.82 (13H, m, aromatic); c(90 MHz, CDC13) 27.90 (tBu CH), 37.82 (CH2), 46.92 
(aCH), 50.56 (Fmoc CH), 67.18 (Fmoc CH2), 81.97 (tBu quaternary), 119.82, 
121.13, 124.93, 124.98, 126.00, 126.91, 127.56, 129.33 (aromatic CH), 141.11, 
143.51, 143.66, 150.50 (aromatic quaternary) 155.84, 169.57, 169.96, (CO 
quaternary); m/z (FAB) 488 (MH); HRMS: Found 488.20727. C29H30N06 requires 
488.20730. 
Na9Fluoreny lmethoxycarbonylaspartic acid-ct-phenyl ester (48) 
Na9Fluorenylmethoxycarbonylaspartic acid-ct-phenyl-3-tertiary butyl ester (3.1 g, 
6.3 mmol) was dissolved in distilled dichioromethane (10 ml) and stirred for 3 hours 
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at room temperature with trifluoroacetic acid (2 ml). Upon removal of the solvent 
under reduced pressure and trituration with ether the title compound (2.23 g, 81%) 
was obtained as a white powder, m.p. 171-173°C (Found: C, 69.15; H, 5.0; N, 3.3. 
C25H2 1 N06 requires C, 69.6; H, 4.9; N, 3.25%); [ix]D22  -37.6° (c 0.5, DMF); TLC 
Rf (A) 0.43 Rf (B) 0.82; ?.max(MeOH)/nm 396,288 and 265 (c/dm 3mol 1cm 1 6552, 
5862 and 22414); v max(CHC13)/cm' 3431 (NH), 3067, 3032 (CH), 1766 (ester CO), 
1721 (urethane CO), 1594 (aromatic), 1509 (amide II); H(200 MFIz, (CD3)2S0) 
2.59-3.06 (2H, m, 3CH2), 4.25-4.4 (3H, m, Fmoc CH2, Fmoc CH), 4.59-4.70 (1H, 
m, aCH), 6.77 (1H, d, NH), 7.06-8.10 (13H, m, aromatic); c(90 MHZ, (CD3)2S0) 
34.88 (CH), 46.76 (aCH), 50.57 (Fmoc CH2), 115.41, 118.98, 120.27, 121.81, 
125.15, 125.23, 125.41, 127.24, 127.83, 129.52 (aromatic CH), 140.95, 143.77, 
143.94 (aromatic quaternary), 157.50, 170.00, 172.31 (CO quaternary); m/z (FAB) 
432 (MH); HRMS: Found 432.14468. C25H22NO6 requires 432.14470. 
cx9F1uoreny1methoxycarbonyl aspartic acid-a-phenyl- -dibenzosubery1 ester (49 
Na9F1uorenyImethoxycarbonylaSPartic acid-a-phenyl ester (2 g, 4.6 mmol) and 
dibenzosuberol (1 g, 4.7 mmol) were dissolved in distilled dichloromethane (50 ml) 
and cooled to 0°C then dicyclohexylcarbodiimide (0.98 g, 4.7 mmol) and DMAP (50 
mg) were added. After 5 days stirring at room temperature the solution was filtered, 
evaporated and dissolved in ethyl acetate (150 ml). This was washed with 1M 
sodium hydrogen carbonate (2 x 100 ml) and water (100 ml) then dried over 
magnesium sulphate. Upon removal of approximately two thirds of the volume of 
the solvent in vacuo light petroleum(40-6O) was added to precipitate the title 
compound (1.97 g, 68%) as a white solid upon recrystalisation from ethanol, m.p. 
135-137°C (Found; C, 75.9; H, 5.5; N, 2.4. C40H33NO6 requires C, 77.0; H, 5.3; N, 
2.25%); [a]D +6.80 (c 0.5, CH2C12); TLC- Rf (F) 0.76, Rf (A) 0.98; 
Xmu(MeOH)/nrn 300, 289 and 265 (EJdm 3mol 1 cm 1  57291, 46875 and 204167); 
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vmax(CHC13)/cm' 3430 (NH), 3067 and 3032 (CH), 1769 (CO ester), 1601 
(aromatic), 1508 (amide II); H(200 MHz, CDC1 3) 2.97-3.73 (6H, m, f3CH2, Dbs 
CH2CH2 ), 4.17-4.47 (3H, m, Fmoc CH 2, Fmoc CH), 4.82-4.91 (1H, m, aCH), 5.86 
(IH, d, NH), 6.8-7.76 (21H, m, Dbs 5H, aromatic); 8c(90 MHz, CDC13) 32.12 and 
32.28 (Dbs CH2CH2), 36.99 (I3CH2), 46.89 (ctCH), 50.37 (Fmoc CH), 67.20 (Fmoc 
CH2), 80.47 (Dbs 5CH), 119.80, 121.08, 124.97, 125.94, 126.01, 126.09, 126.92, 
127.55, 128.84, 128.90, 129.25, 129.93, 130.22, 130.22, 130.29, (aromatic CH), 
135.67, 135.83, 140.00, 140.16, 141.10, 143.50, 143.60, 150.17 (aromatic 
quaternary), 155.17, 169.21, 169.74 (CO quaternary); m/z (FAB) 624 (MH); 
HRMS: Found 624.23863. C40H34N06 requires 624.23859. 
Dibenzosubervl acetate (52) 
Dibenzosuberol (2.1 g, 10 mmol) was dissolved in distilled acetic anhydride (3 ml) 
and pyridine (5 ml) then stirred at room temperature for one day. The solution was 
exhaustively evaporated and water (15 ml) was added. The aqueous phase was 
extracted with diethyl ether (2 x 25 ml) then the organic phase was dried (MgSO4) 
evaporated and triturated with light petroleum (40-60) to yield the title compound 
(1.72 g, 68%), m.p. 85-87°C (lit. 110, 87 0C), TLC- Rf (E) 0.55, Rf (F) 0.71: 
vm (CHC13)/cm 1  3032 (CH), 1730 (CO); 8H(80 MHz, CDC13) 2.08 (3H, s, CH3), 
2.84-3.76 (4H, m, CH2-CH2), 6.93 (1H, s, 5-CH), 7.08-7.50 (8H, m, aromatic CH). 
4-Nitrobenzvl acetate (51) 
4-Nitrobenzyl alcohol (4 g, 26 mmol) was dissolved in acetic anhydride (5 ml) and 
pyridine (5 ml) then stirred overnight. The solution was then poured into water (50 
ml) and extracted with diethyl ether (2 x 50 ml). The combined organic phase was 
evaporated to provide the title compound (4.1 g, 78%), m.p. 75°C (Lit.", 74-77°C); 
vmax(CH2C12)/cm 1 3030, 2890, 2990 (CH), 1760 (ester CO); H( 80  MHz, 
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(CD3)2C0), 2.12 (314, s, CH 3), 5.26 (21-1, s, CH2), 7.68 (2H, d 3J 8.9 Hz, aromatic 
H2 and H6), 8.26 (2H, d 3J 8.8 Hz, H3 and 145). 
Dibenzosubervl hydrocinnamate (53) 
Hydrocinnamic acid (3.7 g, 25 mmol) was dissolved in dry benzene (40 ml) 
containing oxalyl chloride (8 ml) and refluxed for 1 hour, cooled then evaporated. 
The residue was then evaporated twice more from dry dichioromethane before 
dissolving in dichloromethane (40 ml) to which pyridine (10 ml) and dibenzosuberol 
(5.25g, 25 mmol) were added. After refluxing for 1 hour the cooled solution was 
diluted with dichloromethane (50 ml) then washed with 2M hydrochloric acid (100 
ml), 2M sodium hydroxide (100 ml) and dried (MgSO4). Removal of the solvent in 
vacuo and trituration with n-hexane then recrystallisation from n-hexane gave the 
title compound (6.8 g, 80%), m.p. 72°C (Found: C, 84.25; H, 6.65. C24H2202 
requires C, 84.2; H, 6.4%); TLC- R f (E) 0.61, Rf (A) 0.82; ax(CH2Cl2)/flm 266 
(Jdm3moI 1 cm 1 986); Vmax(CH2C12)/Cm' 3060, 2987 and 2945 (CH), 1740 (CO), 
1604 (aromatic); H(200  MHz,CDC13) 2.62-2.73 (2H, m, CH2), 2.98-3.06 (4H, m, 
CH2), 3.46-3.58 (2H, m, CH2), 7.05-7.45 (12H, m, aromatic); 5690 MHz, CDCI3) 
30.64 (CH2CO), 32.10 (dibenzosuberyl CH 2CH2), 36.00 (benzylic CH2), 78.79 
(CH), 125.88, 127.95, 128.18, 128.45, 129.46 and 130.03 (aromatic CH), 136.33 and 
139.80 (dibenzosuberyl quatemary), 140.03 (hydrocinnamoyl quaternary), 171.40 
(CO); m/z (FAB) 342 (M); HRMS: Found 342.16199. C 24H2202 requires 
342. 16197. 
4-fluorophenylacetic acid methyl ester (55) 
4-Fluorophenylacetic acid (82.75 g, 0.53 mol) was dissolved in methanol (500 ml) 
containing concentrated sulphuric acid (5 ml) then heated at reflux for 8 hours. The 
cooled solution was poured into water (1000 ml) then extracted twice with ethyl 
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acetate (250 ml). The combined organic phase was washed with 1M sodium 
hydrogen carbonate (250 ml) and brine (250 ml) then dried (Na2SO4) and 
evaporated to yield an oil that upon distillation gave the title compound (44.7 g, 
80%) as a clear liquid, b.p. 80°C/0.9 mmHg (lit. 68, 590C/0.2 mmHg); v(liquid 
film)/cm 1 3030 and 2980 (CH), 1755 (CO), 1610 (aromatic); H(200  MHz, CDCI3) 
3.58 (2H, s, CH2) 3.67 (3H, s, CH 3) 6.93-7.28 (4H, m, aromatic). 
1 -(4'-Fluoroohenvl)-2-methvlpronan-2-ol 
To a suspension of magnesium turnings (27 g, 1.1 mol) in diethyl ether (30 ml) 
stirred under a stream of nitrogen was added iodomethane (15.6 ml, 1.1 mol) in 
diethyl ether (100 ml) with cooling. 4-Fluorophenylacetic acid methyl ester (79 g, 
0.47 mol) in diethyl ether (100 ml) was slowly added. After stirring at room 
temperature for one day the solution was poured into 2M ammonium chloride/ice 
slurry (1 litre) then extracted with approximately 500 ml of diethyl ether. The 
organic solution was washed with water (250 ml) and brine (250 ml) then dried over 
sodium sulphate and evaporated. The title compound (67.8 g, 85%) was obtained 
upon vacuum distillation as a clear liquid, b.p. 74°CI0.4 mmHg (lit.68, 68°C/0.6 
mmHg); Vmax(CHC13) /cm 1 3600 (free OH), 3460 (br., H-bonded OH), 2960 and 
2810 (CR), 1610 (aromatic); H(80  MHz, CDC13) 1.17 (6H, s, (CH3)2), 1.67 (1H, s, 
OH), 2.69 (2H, s, CH2) 6.82-7.23 (4H, m, aromatic). 
NOC-Benzyloxycarbonylaspartic acid-c-benzyl- 3-(4'-fluorophenvfl-2-methylprop-2-
yl ester (57) 
NaBenzyloxycarbonylaspartic acid-a-benzyl ester (10 g, 28 mmol) and 1-(4'-
fluorophenyl)-2-methylpropan-2-ol (4.2 g, 25 mmol) were dissolved in distilled 
dichloromethane (100 ml) and cooled to 0°C. Dicyclohexylcarbodiimide (6.2 g, 30 
mmol) and DMAP (300 mg) were added. After 3 days the solution was filtered and 
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the solvent removed in vacuo. The residue was dissolved in ethyl acetate (250 ml) 
and filtered once more then washed with 10% sodium carbonate (200 ml), dried 
(MgSO4) and evaporated to give an oil that was purified by flash chromatography 
over silica gel, eluted with 20% ethyl acetate in hexane. Precipitation from diethyl 
ether using hexane then recrystallisation from pentane gave the title compound (7.3 
g, 57%), m.p. 50°C (Found: C, 68.0; H, 5.9; N, 2.7. C29H30FN06 requires C, 68.6; 
H, 5.9; N, 2.7%); [a]022  -8.8° (c 0.5, CH202); TLC- Rf (H) 0.27, R f (A) 0.84; 
?(CH202)/nm 258, 266 and 271 (eJdm 3molcm 1 980, 1081 and 737); 
vm (CH2Cl2)/cm 1 3445 (NH), 3033, 2981 and 2945 (CH), 1729 (ester CO), 1604 
(aromatic), 1509 (amide II); H(200  MHz, CDC13) 1.37 (6H, s, (CH3)2), 2.7 1-2.94 
(2H, m, CH2), 2.97 (2H, s, fluorophenyl CH2), 4.60-4.69 (1H, m, aCH), 5.13 and 
5.18 (4H, s, benzyl and benzyloxycarbonyl CH 2), 5.79 (1H, d, NH), 6.88-7.11 (4H, 
m, fluorophenyl aromatic), 7.34 (10H, s, benzyl and benzyloxycarbonyl aromatic); 
F(75  MHz, CDC13) -120.19; 5c(50 MHz, CDC13) 25.37 and 25.44 (2 x CH2), 37.34 
(13CH2), 44.82 (CH2-(CH3)2), 50.22 (aCH), 66.63, 66.97 (benzylic CH2), 82.95 
(quatemary C(CH3)2), 114.47 (d, 3CF  21.1 Hz, C2, C6) 127.71, 127.80, 127.99 and 
128.15 (benzyl and benzyloxy aromatic CH), 131.46 (d, 2JCF 7.5 Hz, aromatic C3, 
C5), 134.90 and 135.85 (benzylic CH2), 155.65 (fluorophenyl C 1 ) 161.36 (d, IJCF  
224 Hz, fluorophenyl C4), 169.69, 170.38 (CO); m/z (FAB) 508 (MH); HRMS: 
Found 508.21354. C29H3 1 FN06 requires 508.21352. 
Aspartic acid-p- 1—(-4'-fluorophenvl)-2-methvlprop-2-vl ester (58) 
NaBenzy1oxycarbonyaspartic acid-a-benzyl- - 1 -(4'-fluorophenyl)-2-methylprop-2-
yl ester (5.3 g, 0.01 mol) was dissolved in aqueous methanol (98% v/v. 50 ml) and 
stirred with 10% palladium on charcoal (500 mg) for 90 minutes under an 
atmosphere of hydrogen. The solution was filtered through celite to remove the 
catalyst then the solvent was removed in vacuo. Trituration with ether then treatment 
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of the mother liquors with n-hexane gave a solid which was recrystallised from 
methanol/ether to give the title compound (2.5 g, 88%) as a white solid, m.p. 215°C 
(Lit.68 , 169-172°C); (Found: C, 60.2; H, 6.9; N, 5.0. C 14H 18NF04 requires C, 59.35; 
H, 6.4, N, 5.0%); [a]D22  + 1.8° (c 0.5, DMF); TLC- Rf (B) 0.9, Rf (C) 0.4; H(200  
MHz, CD30H) 1.55 (6H, s, (CH3)2), 2.80-3.09 (2H m, f3CH2), 3.15 (2H, s, CH-
(CH3)2), 3.88-3.94 (IH, m, (xCH), 7.05-7.35 (4H, m, aromatic); m/z (FAB) 284 
(MH); HRMS: Found 284.12981. C 141-1 19FN04 requires 284.12980. 
a9FluorenvlmethoxvcarbonyIaspartic acid- 3-(4'-fluorophenvfl-2-methvlprop-2-
yl ester (59) 
Aspartic acid--1—(4'-fluorophenyl)-2-methylprop-2-yl ester (1 g, 3.5 mmol) in 
water (5 ml) containing triethylamine (0.6 ml, 5.8 mmol) was stirred with 9-
fluorenylmethyl-succinimidyl carbonate (1.2 g, 3.5 mmol) for 24 hours. This was 
then poured into water (25 ml) and acidjfied with 2M potassium hydrogen sulphate 
to approximately pH 3 then extracted with ethyl acetate (250 ml). The organic phase 
was washed with water (100 ml), dried (MgSO4) and evaporated to give a gum 
which was dissolved in boiling toluene and cooled overnight to yield the title 
compound(1.4 g, 76%) as a white solid, m.p. 115-117°C (Found: C, 68.7; H, 5.7; N, 
2.8. C29H28FN06 requires C, 68.9; H 5.6; N, 2.8%); [ct]D22  -1.20 (c 1.0, EtOH); 
TLC- Rf (A) 0.26; ? ax(CH2C12)/nm 302, 290 and 268 (Jdm 3mol 1cm 1 5254, 
6102 and 22557); Vmax(CH2C12)/cm1  3440 (NH), 2850 (CH), 1760 (urethane CO), 
1719 (ester CO), 1605 (aromatic), 1510 (amide II); 6H(200  MHz, CDC13) 1.40 and 
1.44 (6H, s, (CH3)2), 2.81-3.10 (4H, m, 13CH2, CH2-(CH3)2), 4.19-4.45 (3H, m, 
Fmoc CH2 and CH), 4.62-4.67 (IH, m, aCH), 5.78 (111, d, NH), 6.94-7.77 (12H, m, 
aromatic); c(50 MHz, CDC1 3) 25.70 (2 x CH3), 37.37 (CH2), 45.12 (CH2 
(CH3)2), 46.82 (ctCH), 50.08 (Fmoc CH), 67.26 (Fmoc C11 2), 83.68 (CH2-C-
(CH)3)2-0), 114.73 (d, 3CF  20.9 Hz, C2, CO,  119.81, 124.92, 126.91, 127.57 
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(Fmoc aromatic CH), 131.64 (d, 2CF  7.8 Hz, C3, C5), 141.09, 143.41, 143.57 
(Fmoc quatemary), 155.99 (fluorophenyl C 1 ), 161.61 (d, IJCF 244 Hz, C4), 170.25 
and 170.86 (CO); m/z (FAB) 506 (MH); HRMS: Found 506. 19788. C29H29FN06 
requires 506.19787. 
L-Aspartic acid copper (IT) complex copper (II) salt octahydrate (62) 
To a solution of aspartic acid (26.6 g, 200 mmol) in water (1000 ml) at 70°C was 
added a solution of copper(1I)acetate (41.2 g, 206 mmol) in water (750 ml) over a 
period of 1 to 2 hours. This was left to stand for 2 days then filtered and washed with 
water, ethanol and ether to yield a blue solid which was then used without further 
characterisation (52.1 g, 98%). 
hloromethylanthracene (61 
9-Anthracenylmethanol (15.0 g, 72 mmol) was dissolved in dry benzene (100 ml) 
containing thionyl chloride (1.2 eq.,6.0 ml, 86 mmol) then heated at reflux for 4 
hours. The cooled solution was evaporated exhaustively to provide a crude yellow 
solid. This was then triturated and washed with cold diethyl ether to provide the title 
compound (11 g, 68%), m.p.132-135°C (Lit. 112 , 141-142.5°C); H(200  MI-Iz, 
CDC13) 5.55 (2H, s, CH2),7.46-7.65 (4H, m, aromatic H 2,H3,H6 and H7), 7.97-8.01 
(2H, m, aromatic H 1  and H8), 8.27-8.3 1 (2H, m, aromatic H4 and H5), 8.41 (1H, s, 
aromatic H 1 0). 
Aspartic acid-3-9-anthracenylmethv1 ester (63) 
L-Aspartic acid copper (II) complex copper (II) salt octahydrate (2.98 g, 5.6 mmol) 
and aspartic acid (1.5g, 11.2 mmol) were dissolved in DMF (10 ml) and water (1.6 
ml) then tetramethylguanidine (2.8 ml, 22.4 mmol) was added and the solution 
stirred for 2 hours at room temperature. 9-Chloromethylanthracene (5.35 g, 24 
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mmol) was added and the reaction left overnight then acetone was added to give a 
fine precipitate which was filtered then resuspended in water and ground with a glass 
rod to break up the solid before filtering once more. This solid was then suspended 
in a solution containing ethylenediaminetetraacetic acid (3.2 g, 11 mmol) and 
sodium hydrogen carbonate (1.8 g, 22 mmol) in water (25 ml) and then shaken 
vigorously for 1 hour. Upon dilution with water (30 ml approx.) the title compound 
(3 g, 40%) precipitated as a yellow solid which was washed copiously with ether, 
m.p.175°C; (Found: C, 66.0; H, 5.4; N, 3.7. C 19H 17N04 requires C, 70.6; H 5.3; N, 
4.3%); [cx] D22  -32.5° (c 0.04, DMF); TLC- R(C) 0.63, Rf(B) 0.84; max(3)/nm 
365, 386 and 410 (E/dm 3mol 1 cm 1 3426, 4074 and 4074); v m (bromoform 
mulI)/cm' 3392 (br., ammonium), 2933 (CH), 1703 (carboxyl CO), 1633 (amino 
acid I) 8H(80  MHz, (CD3)2S0) 2.07 (2H, m, 3CH2), 6.13 (2H, m, Ar-CH2) 7.55- 
8.71 (9H, m, aromatic); m/z (FAB) 323 (M); HRMS: Found 323.11577. 
C 1 9H 17N04 requires 323.11575. 
NcL9Flprenylmethyloxycarbonylaspartic acid--9-an thracenylmethyl ester (64 
9-Fluorenylmethyl-s ucci nim idyl carbonate (3.1 g, 9.2 mmol) and aspartic acid--9-
anthracenylmethyl ester (2.5 g, 7.7 mmol) were stirred in 60% aqueous dioxane (60 
ml) containing triethylamine (1.6 ml, 11 mmol) for 1 day at room temperature. 
Water (100 ml) was added and the solution was acidified to pH 3 with 2M potassium 
hydrogen sulphate then extracted with ethyl acetate (3 x 250 ml). The combined 
organic solutions were washed with water (100 ml), brine (100 ml) and dried 
(MgSO4) then evaporated under reduced pressure to yield the title compound (1.8 g, 
42%) as a solid which was recrystallised from chloroform/light petroleum(60-80), 
m.p.150-155°C (Found: C, 71.0; H, 4.95; N, 2.3. C 34H27N06 requires C, 74.8; H, 
4.95; N, 2.3%); [a]D22  -9.5°(c 2.0, DMF); TLC- R f (A) 0.12, Rf (B) 0.87; 
Amax(Me0F1)11m 288, 300, 347, 365 and 385 (c/dm 3mol 1 cm 1 4148, 4258, 3057, 
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4585 and 4367); Vmax (CH2C12)/cm' 3426 (NI-I), 1730 (CO urethane), 1610 
(aromatic), 1512 (amide II); H(80  MHz, CDC1 3) 2.75-3.92 (2H, m, CH2), 3.95-
4.82 (4H, m, xCH, Fmoc CH and CH 2), 5.95 (2H, br. s, anthracenyl CH2), 5.5-5.75 
(1H, m, NT-I), 6.93-8.30 (17H, m, aromatic); c(50 MHZ, (CD 3 )2S0) 37.10 (I3CH), 
46.79 (aCH), 51.89 (Fmoc CH), 58.65 (anthracenyl CH2), 65.75 (Fmoc CH2), 
120.26, 125.39, 125.96, 126.46, 126.87, 127.24, 127.77, 129.05 (aromatic CH), 
130.64, 131.01 and 131.61 (anthracenyl quatemary), 143.98 and 140.85 (Fmoc 
quaternary), 155.90 (esterCO), 171.16 (urethane CO), 173.82 (acid CO); m/z (FAB) 




9-Anthracenylmethanol (4.1 g, 20 mmol) and hydrocinnamic acid (3.7 g, 25 mmol) 
dissolved in distilled dichloromethane (100 ml) and cooled to 0°C were combined 
with DCC (5.1 g, 25 mmol) and DMAP (100 mg) then stirred for 2 days at room 
temperature. The solution was filtered to remove dicyclohexylurea then the solvent 
was removed in vacuo. The residue thus obtained was dissolved in ethyl acetate (250 
ml) then washed with sodium carbonate (10%, 200 ml), dried over magnesium 
sulphate and the ethyl acetate removed in vacuo. The title compound (4.4 g, 65%) 
was obtained as a solid from diethyl ether/light petroleum (60- 80), m.p. 78°C 
(Found: C, 84.5; H, 6.1. C24H2002 requires C, 84.7; H, 5.9%); TLC- R f (A) 0.83, Rf 
(E) 0.74; Xmax (Me0}1)111m 384, 364, 346 and 330 (€/dm 3mol 1cm 7672, 8354, 
5541 and 2728); vmax (CH2C12)/cm' 3033 and 2936 (CH), 1734 (CO) H(200  MHz, 
CDCI3) 2.62-2.70 (2H, m, CH 2C0), 2.91-2.99 (2H, m, benzylic CH2), 6.13 (211, m, 
anthracenyl CH 2), 7.10-7.30 (4H, m, anthracenyl aromatic), 7.39-7.60 (5H, m, 
hydrocinnamyl aromatic), 8.00-8.05 (2H, m, anthracenyl aromatic), 8.25-8.29 (2H, 
m, anthracenyl aromatic), 8.50 (1H, s, anthracenyl H10); 6c(90 MHz, CDC13) 30.72 
(CH2CO), 35.56 (hydrocinnamate benzylic CH 2), 58.55 (anthracenyl CH2), 123.68, 
124.83, 125.97, 126.37, 128.02, 128.84, 128.93 (aromatic) 130.76, 131.08 
(anthracenyl quatemary), 140.06 (hydrocinnamyl quaternary) 172.84 (CO); m/z 
(FAB) 341 (MW); HRMS: Found 341.15415. C2 4H2 1 02 requires 341.15414. 
1-(9'-Anthracenvl')-2-methvlpropan-2-ol (65) 
To a solution of 9-bromoanthracene (5.2 g, 0.02 mol) in dry, distilled THF (20 ml) 
stirred under nitrogen and cooled to -78°C was added n-butyllithium (1.6 moldm' 3 , 
12.5 ml, 0.02 mol). Upon complete addition of the base, isobutylene oxide (1.8 ml, 
0.02 mol) was added and the mixture was allowed to warm to room temperature. 
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After three hours the reaction was poured into 2M ammonium chloride/ice slurry 
(100 ml) then extracted with diethyl ether (2 x 200 ml), dried (MgSO 4) and the 
solvent removed in vacuo. After trituration with n-hexane and recrystallisation from 
ethanol/water the title compound (2 g, 40%) was obtained as a pale grey solid, m.p. 
112-113°C (Found: C, 85.8; H, 7.1. C 1 8H 1 80 requires C, 86.4; H, 7.2%); TLC- Rf 
(A) 0.72 Rf (H) 0.29; Xax(MeOH)/nm  347, 365 and 385 (e/dm 3molcm 6477, 
10625 and 10454); vm (CH2Cl2)/cm' 3587 (OH), 2987 (CH), 1621 (aromatic); oH 
(80 MHz, CDCI 3) 1.33 (6H, s, (CH3 )2), 1.38 (1H, s, OH), 3.91 (2H, s, CH2) 7.23-
7.53 (4H, m, aromatic H2, H3, H6, H7), 7.93-8.06 (2H, m, aromatic H 1 , H8), 8.32-
8.45 (3H, m, aromatic H 4, H5, H10); 0c(90 MHz, CDC1 3) 30.82 ((CH3)2), 39.75 
(CH2), 73.20 (COH), 124.02, 124.53, 125.15, 126.02, 128.19 (aromatic CH), 
129.55, 130.51, 130.72 (aromatic quaternary); m/z (FAB) 250 (M); HRMS: Found 
250.13574. C 18H 1 80 requires 250.13576. 
1-(9'-Anthracenvl)-2-methvlprop-2-ene (67) 
1-(9'-Anthracenyl)-2-methylpropan-2-ol (500 mg, 2 mmol) was dissolved in benzene 
with 4-toluenesulphonic acid and heated at reflux for 3 hours The cooled solution 
was then washed with 10% sodium carbonate (2 x 50 ml) and brine (100 ml) then 
dried (MgSO4). This was then evaporated to yield the title compound (420 mg, 90%) 
as a yellow oil, TLC- Rf (A) 0.83, R f (E) 0.78; 2 ax(CH2Cl2)/nm 352, 370 and 290 
(e not calculated); 0H(200  MHz, CDC1 3) 1.50 (3H, d, 4J 1.5 Hz, Z-CH3), 2.25 (3H, 
d, 4J 1.2 Hz, E-CH 3), 6.87 (IH, m, CH), 7.25- 7.58 (4H, m, aromatic), 8.02-8.27 
(4H, m, aromatic), 8.43 (IH, s, aromatic H10); 0c(50 MHz, CDC13) 19.75 and 25.42 
(Cl-I3), 120.89 (CH), 124.87, 125.53, 126.41, 128.00, 128.45 (aromatic CH), 129.68, 
131.31, 133.33, 138.69 (quaternary); m/z (FAB) 232 (M); HRMS: Found 
232.12521. C 18H 16 requires 232.125 19. 
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Diethvl-2-(9'-anthracenylmethyl)malonate (73 
Diethyl malonate (1.8 ml, 12 mmol) was added dropwise to a suspension of 50% 
sodium hydride (570 mg, 12 mmol ) in dry THF (50 ml) cooled in an ice/water bath. 
To this was added 9-choloromethylanthracene (2.5 g, 11 mmol) in THF then the 
reaction was stirred for 18 hours. The solvent was partially evaporated then the 
solution diluted with water (200 ml) and the pH was adjusted to between 3 and 5 
with 2M potassium hydrogen sulphate before extracting with ethyl acetate (300 ml). 
This solution was dried over magnesium sulphate then evaporated to yield, upon 
trituration with cyclohexane, the title compound (1.85 g, 48%) as a yellow solid, 
m.p. 68-71°C; TLC- R f (A) 0.77, Rf (G) 0.47; 7max(CH2 2)/nm 368, 388 and 407 
(cjdm3mol 1 cm 1 5639, 7194 and 6222); v max(CHC13)/cm 1 3060 and 2980 (CH) 
1760 (CO); H(80  MHz, CDC13) 1.03 (6H, t, 3J 7.1 Hz, Cl-I3) 3.83-4.34 (7H, m, 
benzylic CH2, CH, 2 x CH2 ethyl) 7.32-8.36 (9H, m, aromatic); c(90 MHz, CDC1 3) 
13.64 (CH3), 61.41 (CH2), 123.98, 124.72, 125.78, 126.89 and 129.16 (aromatic 
CH), 129.77, 128.33 and 131.30 (aromatic quaternary), 169.10 (CO); m/z (FAB) 350 
(M); HRMS: Found 350.15 180. C 22H2204 requires 350.15 180. 
2-(9'-Anthracenylmethvl)-malonic acid (74) 
Method (A) 
Diethyl-2-(9'-anthracenylmethyl)-malonate (200 mg, 570 mmol) was dissolved in 
acetone (40 ml) and sodium hydroxide (60 mg) in water (10 ml) was added. This 
was heated at reflux for 2 hours then diluted with 2M sodium hydroxide (100 ml) 
and washed with diethyl ether (100 ml). The aqueous layer was then acidified with 
concentrated hydrochloric acid and extracted with toluene (2 x 100 ml), dried 
(MgSO4) and evaporated to give upon trituration with n-hexane the title compound 
(132 mg, 92%), m.p. 205°C (decomp) (lit. 113 , 209-210°C); 6H(200  MHz, (CD3)2C0) 
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3.92 (111, t, 3J 7.3 Hz, CH), 4.31 (2H, d, 3J 7.3 Hz, CH2), 7.46-7.61 (4H, m, 
aromatic H2, H3 , H6 ,H7), 8.06-8.11 (21-1, m, aromatic H 1 , H8), 8,41-8.51 (31-1, m, 
aromatic H4, H5 , H 10). 
MIfI)1 
Diethyl-2-(9'-anthracenylmethyl)-malonate (1 g, 2.8 mmol) in dioxane (10 ml) 
containing concentrated hydrochloric acid (5 ml) and water (5 ml) was heated at 
reflux for 4 hours. The cooled solution was made basic with 2M NaOH then washed 
with ether (2 x 100 ml). The aqueous layer was acidified with concentrated 
hydrochloric acid and repeatedly extracted with ethyl acetate, dried over magnesium 
sulphate and evaporated. Trituration with hexane provided the title compound (560 
mg, 68%). Analytical data was consistent with that found in method (A). 
1-(9'-Anthracenvl)-propionic acid (75 
2-(9'-Anthracenylmethyl)-malonic acid (200 mg, 0.68 mmol) was dissolved in 
tetrahydronaphthalene (20 ml) and heated at reflux until evolution of carbon dioxide 
ceased (90 mm) then extracted with 6M sodium hydroxide (200 ml). The aqueous 
phase was washed with pentane (2 x 100 ml), acidified with concentrated 
hydrochloric acid and extracted with ethyl acetate (2 x 75 ml). The combined 
organic phase was dried (MgSO4) and the solvent removed in vacuo. The resultant 
oil was triturated with hexane to give the title compound (100 mg, 59%), m.p. 186-
1890C (lit) 14 , 194°C); TLC R f (A) 0.64, Rf (B) 0.9; v max(CH2C12)/cm4 3495 (OH), 
2800-3300 (br OH), 3066, 2989 (CH), 1712 (CO); 8H(200 MHz, (CD3)2S0) 2.62 
(2H, t, 3J 8.32 Hz, CH), 3.86 (211, t, 3J 7.99 Hz, CH), 7.48-7.62 (4H, m, aromatic 
H2, H3, H6, H7), 8.07-8.12 and 8.29-8.51 (411, m, aromatic (H 1 and H8),(H4 and 
H5)), 8.58 (1H, s, aromatic H 10). 12.36 (IH, br. s, COOH). 
1-(9'-Anthracenvl)-propionic acid methyl ester (76 
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1-(9'-Anthracenyl)-propiOfliC acid (12.7 g, 0.05 mol) was dissolved in methanol (250 
ml) containing concentrated sulphuric acid (3 ml) then heated at reflux for 18 hours. 
The cooled solution was poured into water (700 ml) then extracted with ethyl acetate 
(2 x 250 ml). The combined organic layers were then washed with 10% sodium 
hydrogen carbonate (300 ml), dried (MgSO4) and evaporated to yield a yellow solid. 
Recrystallisation from ethanol/water gave the title compound (11 g, 85%), m.p. 68- 
70°C (Found; C, 80.8; H, 6.1. C 1 8H 1 602 requires C, 81.8; H, 6.1%); TLC- R f (E) 
0.6, Rf (G) 0.47; max (C112C12)/nm 333, 349, 368 and 388 (€/dm 3mol4cm 2160, 
4560, 7320 and 6960); Vmax(CH2Cl2)/cm 3072 and 2950 (CH), 1731 (CO), 1601 
(aromatic); H(200  MHz, CDC13) 2.75-2.83 (2H, m, CH 2CO), 3.74 (3H, s, CH3), 
3.77-4.01 (2H, m, benzylic CH 2), 7.47-7.58 (4H, m, aromatic H 2, H3 , II6, H7), 7.95-
8.03 (2H, m, aromatic H 1 , 148), 8.24-8.36 (3H, m, aromatic H4, H5 , H 1 0); 8c(90 
MHz, CDC13) 23.07 (CH2CO), 34.68 (benzylic CH 2), 51.56 (OCH3), 123.64, 
124.69, 125.71, 126.19, 129.11 (aromatic CH), 129.24, 131.35, 132.09 (aromatic 
quatemary), 173.26 (CO); m/z (FAB) 264 (Mt); HRMS: Found 264.11508. 
C 1 8H1602 requires 264.11503. 
3-(9'-Anthracenvlmethyl)-tertiarv butylacetoacetate (78) 
Sodium hydride (80 %, 1.2 g, 39 mmol) was suspended in dry THF and stirred at 
0°C. To this was added tertiary butylacetoacetate (6.3 ml, 38 ml) and 9-
chloromethylanthracene (8.8 g, 38.8 mmol), then the reaction was heated at reflux 
for 3 hours, poured into ice/water and the pH adjusted to pH 6. This was extracted 
with ethyl acetate and the organic solution washed with brine and dried (MgSO 4). 
Evaporation of the solvent under reduced pressure yielded the title compound (10 g, 
74%) as an oil which was used without further purification, TLC- R f (E) 0.43; 
vmax (CHC13)/cm' 3030, 2985 and 2935 (CH), 1733 (ester CO), 1712 (ketone CO); 
H(360 MHz, CDC1 3) 1.23 (9H, s, C(CH 3 )3), 2.08 (3H, s, COCH3), 3.91 (1H, t, 3J 
7.0 Hz, CH), 4.14-4.24 (2H, m, CH 2), 7.42-7.53 (4H, m, aromatic H 2, H3, H6, H7), 
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7.96-8.02 (21-1, m, H 1 , 1-18), 8.23-8.35 (3H, m, H4 , 1-15 , H 1 0); m/z (FAB) 348 (M); 
HRMS: Found 348.17255. C23H2403 requires 348. 17253. 
I -(9'-Anthrpcenvl)-butan-3-one (79) 
3- (9'-Anthracenylmethyl)- tertiary butylacetoacetate (10 g, 28.7 mmol) was dissolved 
in dichioromethane (50 ml) and then stirred with trifluoroacetic acid (50 ml) for 2 
hours. This was evaporated and then evaporated twice more from dichioromethane 
alone. The solid thus obtained was dissolved in toluene and refluxed for 2 hours 
(until evolution of gas ceased) then evaporated to give an oil purified by dry flash 
chromatography eluting with n-hexane/dichloromethane then dichloromethane to 
give the title compound (6.5 g, 90%), m.p. 83-86°C (Found: C, 86.0; H, 6.3. 
C 1 8H 160 requires C, 87.0, H, 6.5%); TLC- Rf (E) 0.55, Rf (H) 0.3; 
Amax(CH3)1nm 390, 370 and 351 (c/dm 3molcm 8944, 9316 and 5155); 
vm (CHC13)/cm' 3067, 2989 (CH), 1715 (CO), 1602 (aromatic); 6H(360 MHz, 
CDC13) 2.18 (3H, s, CH3), 2.88-2.92 (2H, m, CH 2CO), 3.87-3.91 (211, m, benzylic 
CH2), 7.43-7.53 (4H, m, aromatic H 2, H3, H6, H7), 7.99-8.01 and 8. 19-8.21 (4H, m, 
aromatic H 1 and H2, H4 and 1-15), 8.34 (1H, s, aromatic H 1 0); 8c(90 MHZ, CDC13), 
21.23 (CH2CO), 29.64 (CH3), 44.11 (benzylic CH2) 123.58, 124.60, 125.53, 125.81, 
129.03 (aromatic CH), 131.24, 132.77 (aromatic quaternary), 207.70 (CO); m/z 
(FAB) 248 (M); HRMS: Found 248.12013. C 1 8H160 requires 248.12011. 
1 -(9'-Anthracenyl)-3-methylbutan-3-ol (77) 
Method (A) 
lodomethane (3.4 g, 24 mmol) in dry THF (10 ml) was added to a stirred suspension 
of magnesium turnings (590 mg, 24 mmol) in dry ether over 10 minutes to form the 
Grignard reagent as a greyish suspension. To this was added 1-(9'-anthracenyl)-
butan-3-one (5 g, 20 mmol) in TI-IF (80 ml) then the mixture was refluxed for 4 
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hours and cooled. The solution was then poured into a cold solution of 1M 
arnmonium chloride and extracted with ethyl acetate (3 x 200 ml). The combined 
organic phase was washed with water (200 ml), brine (200 ml), dried over 
magnesium sulphate and evaporated to produce an oil that was purified over silica 
gel eluting with dichloromethane to yield the title compound (2.8 g, 53%), m.p. 99-
101°C (Found: C, 85.15; H, 8.0 C 19H200 requires C, 86.3; H, 7.6%); TLC- Rf (A) 
0.56, Rf (E) 0.2; Xmax(CH2Cl2)Inm 334, 351, 369 and 390 (eJdm 3mol 1cm 1416, 
3009, 4779 and 4603); v max(CH2Cl2)/Cm' 3605 (OH), 3014, 2931 and 2854 (CH); 
H(200 MHz, CDC13) 1.46 (6H, s, C(CH 3)3), 1.89-2.16 (2H, m, CH2C(CH3)3) 3.66-
3.78 (2H, m, benzylic CH2), 7.22-7.55 (4H, m, aromatic H2, H3, H6, H7), 7.94-8.02 
(2H, m, aromatic H 1 , H8), 8.24-8.33 (3H, m, aromatic H4, H5, H10); c(50 MHZ, 
CDC13) 22.45 (CH2C(CH3)3), 29.03 (2 x CH 3), 44.31 (benzylic CH2), 70.97 (COH), 
123.91, 124.58, 125.31, 125.40, 129.02 (aromatic CH), 129.16, 131.39 and 134.41 
(quaternary aromatic); m/z (FAB) 264 (M); HRMS: Found 264.15140. C 19H200 
requires 264.15141. 
Method (B) 
lodomethane (6 ml, 96 mmol) was added to magnesium turnings (2.3 g, 96 mmol) 
stirred in dry ether under nitrogen. Upon formation of the Grignard reagent 1-(-9'-
anthracenyl)-propionic acid methyl ester (10.5 g, 0.04 mol) in ether was added and 
the reaction left for 24 hours at room temperature then refluxed for 1.5 hours, cooled 
and added to a cold solution of 1M ammonium chloride. After extracting with 
diethyl ether (2 x 200 ml), drying of the solution (MgSO4), removal of the solvent in 
vacuo and trituration with hexane gave a solid. Recrystallisation from ethanol/water 
gave the title compound (8 g, 75%) as a pale yellow solid. Analytical data was 
consistent with that found in method (A). 
1-(9'-Anthracenyl)-3-methylbut-1-yn-3-ol (81) 
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A solution containing 9-bromoanthracene (5 g, 19.5 mmol), triphenyiphosphine (1 g, 
3.9 mmol, 0.2 eq.), 2-methylbut-3-yn-2-ol (3 ml, 29 mmol) and palladium (II) 
acetate (50 mg, 1.9 mmol, 0.1 eq.) in tnethylamine (100 ml) was heated at reflux for 
15 hours. The triethylammonium hydrobromide that precipitated was removed by 
filtration and then the solvent was removed under reduced pressure. The oil obtained 
was dissolved in ether then washed with IM sodium hydrogen carbonate (200 ml), 
2M hydrochloric acid (200 ml), dried (MgSO4) and evaporated. The crude oil was 
purified by dry flash chromatography eluting with dichloromethane and the collected 
fractions crystallised upon evaporation to give the title compound (2.1 g, 41%) as a 
red solid, m.p.155-158°C (Found: C, 85.2; H, 6.4. C 1 9H 1 60 requires C, 87.7; H, 
6.2%); TLC- Rf (A) 0.8, R f (E) 0.14; max(Me0H) 364, 384 and 406 (EJdm 3mol 
1cm' 9509, 9816 and 10123); v m (CHC13)/cm 3598 (OH), 3068, 3021, 2979, 
2933 and 2872 (CH); 5H(200 MHz, CDC13) 1.82 (6H, s, 2 x CH3), 1.84 (1H, s, OH), 
7.41-7.62 (4H, m, aromatic), 7.95-8.22 (4H, m, aromatic), 8.39 (1H, s, aromatic 
H10); c(50 MHz, CDC13) 31.49 (2 x CH 3), 71.51 ((CH3)2COH), 121.11, 123.88, 
124.57, 126.47, 127.00, 127.23, 127.37, 127.86, 130.10 (aromatic CH), 134.07, 
138.16, 148.98 (aromatic quatemary), (alkyne quaternary not observed); m/z (FAB) 
261 (MW); HRMS: Found 260.12010. C 1 9H 1 60 requires 260.12011. 
NaBenzyloxycarbonylaspartic acid-a-benzyl-13- 1 -(9'-anthracenyfl-3-methylprop-3-
yl ester (82 
NaBenzyloxycarbonylaspartic acid-a-benzyl ester (7.8 g, 22 mmol) and 1-(9'-
anthracenyl)-3-methylbutan-3-ol (2.2 g, 8 mmol) were dissolved in distilled 
dichioromethane (100 ml) and cooled to 0°C before the addition of DCC (4.7 g, 23 
mmol) and DMAP (100 mg). The reaction mixture was maintained at 4°C for 4 days 
then filtered and evaporated. The residue was dissolved in ethyl acetate (200 ml) and 
washed with 10% sodium carbonate (200 ml), water (100 ml) and brine (200 ml) 
all 
then dried (MgSO4) and evaporated to yield the title compound as a crude oil (lOg 
crude) that was used without purification, H(200  MHz, CDC13) 1.60 (6H, s, CH3 x 
2), 2.11-2.19 (21-1, m, CH2C(CH3) 2), 2.89-3.21 (2H, m, CH 2), 3.51-3.61 (2H, m, 
anthracenyl CH2-Ar), 4.71-4.75 (1H, m, (tCH), 5.09 (2H, s, benzylic CH2), 5.19 
(2H, s, benzylic CH2), 5.92 (11-1, dr. d., NT-I), 7.27 (10H, s, phenyl x 2), 7.36-7.54 
(4H, m, anthracenyl), 7.97-8.02 (21-1, m, anthracenyl), 8.34 (1H, s, anthracenyl H 1 0); 
m/z (FAB) 603 (M). 
Aspartic acid-13- I -(9'-anthracenyl)-3-methylbut-3-yl ester (83) 
The crude NXbenzy1oxycarbonylaspartic acid-a-benzy1-- 1 -(9'-anthracenyl)-3-
methylprop-3-yl ester (10 g) was dissolved in THF/methanol (3:7, 100 ml) and 
cooled to 0°C before addition of 10% palladium on charcoal (2 g). This was stirred 
under hydrogen for 24 hours. The catalyst was removed by filtration through celite 
and the solvent was removed in vacuo. The title compound was obtained as a yellow 
solid upon trituration with ether 2.4 g (80 % based on 1-(9-anthracenyl)-3-
methylbutan-3-ol), m.p.125-130°C (decomposed); 1aID22  +1.20(c 0.5 DMF); TLC-
Rf (C) 0.54, Rf (B) 0.68; ?ax(MeOH)/nm  348, 365 and 385 (e/dm3mol 1cm4 8046, 
11494 and 11494); Vmax(bromoform muIl)/cm 1 3394 (br.,m.), 2933, 2853 (CH), 
1701 (carboxyl CO), 1637 (amino acid I) H(80  MHz, (CD3)2S0) 1.12 (6H, 5, 
CH3), 1.62-1.84 (2H, m, CH2CO), 2.50-2.59 (211, m, CI-I 2), 3.85-4.00 (2H, m, Ar-
C112), 7.17-8.48 (9H, m, aromatic); m/z (FAB) 380 (MW); HRMS: Found 
380.18621. C23H26N04 requires 380.18617. 
Ncx9Fluprenylmethpxycarbonylaspartic acid- 13-I(9'-anthracenyfl-3-methvlbut-3-vl 
ester (84) 
Aspartic acid- - I -(9'-anthracenyl)-3-methylbut-3-yl ester was dissolved in water (25 
ml). Triethylamine (800 ii, 5.7 mmol) then 9-fluorenylmethyl-succinimidyl 
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carbonate (2.7g, 8 mmol) in dioxane were added. After 3 hours at room temperature 
water (200 ml) was added and 2M potassium hydrogen sulphate was added to bring 
the solution to approximately pH 3. This was extracted with chloroform (2 x 150 ml) 
and this was washed with water (2 x 200 ml), dried (MgSO4) then evaporated. 
Purification by dry column flash chromatography eluted with ether and ether/ethyl 
acetate gave the title compound (2g, 65 %), m.p. 136-140°C (Found: C, 69.8; H, 6.5; 
N, 3.9. C38H34N06 requires C, 75.85; H, 5.85; N, 2.3%); [cx]D 22  -4.20 (c 1.2, DMF); 
TLC- Rf (A) 0.19, Rf (C) 0.88; max(CF103)111m  290, 300, 351, 370 and 390 
(E/dm 3mol 1 cm 1 10635, 10952, 1349, 2222, 2063); vm (CHC13)/cm' 3408 (NH), 
3032, 2938 and 2858 (CH), 1716 (CO), 1606 (aromatic), 1513 (amide II); 8H(200 
MHz, CDC13 55°C) 1.21 (3H, s, CH 3), 1.50 (3H, s, CH 3), 2.76-2.95 (4H, m, 
COCH2, CH2), 3.48-3.98 (1H, m, cxCH), 4.05-4.78 (5H, m, Ar-CH2, Fmoc CH2 , 
Fmoc CH), 6.34 (1H, br. s, NH), 7.11-8.19 (17H, m, aromatic); c(50 MHZ, 
(CD3)2S0) 24.56 (COCH 2), 25.71 (CH 3), 46.81 (CH2CH2), 49.65 (aCH), 52.91 
(CH2), 59.89 (Fmoc CH), 65.62 (Fmoc CH2), 81.81 (C(CH3)2), 120.16-129.05 
(aromatic CH), 131.28, 134.72 (anthracenyl quaternary), 140.82, 144.03 (Fmoc 
quaternary), 155.75, 168.38, 170.77 (CO); m/z (FAB) 601 (MW); HRMS: Found 
601.24648. C38H35N06 requires 601.24642. 
92 
Hvdrocinnamic acid 1-(9'-anthracenyl)-3-methylbut-3-vl ester (95 
1-(9'-Anthracenyl)-3-methylbutan-3-ol (2 g, 7.6 mmol) and hydrocinnamic acid (3.3 
g, 22 mmol) were dissolved in distilled dichioromethane (50 ml) and stirred at 0°C. 
DCC (4.5 g, 22 mmol) and a trace of DMAP were added and the reaction stirred at 
4°C for 5 days. The solution was filtered and evaporated then the residue was 
applied directly to a dry flash column. Elution with dichioromethane then trituration 
with hexane gave the title compound (1.7 g, 56%), m.p. 94-96°C; TLC- R f (F) 0.83, 
R(E) 0.65; ax(CH3)/u1m 349, 367 and 388 (e/dm 3mo1cm 980, 1617 and 
1519); vmax(CHC13)/Cm' 3031, 2934 and 2856 (CH), 1719 (CO); 5H(200 MI-Iz, 
CDC13) 1.65 (6H, s, CH3 x 2), 2.09-2.18 (2H, m, CH2C(CH3)2), 2.66-2.78 (21-1, m, 
CH2CO), 2.95-3.09 (2H, m, CH2-Ar hydrocinnamoyl), 3.54-3.63 (2H, m, CH2-Ar 
anthracenyl), 7.13-7.34 (4H, m, anthracenyl aromatic), 7.41-7.55 (5H, m, 
hydrocinnamyl aromatic), 7.98-8.03 (214, m, anthracenyl aromatic), 8.19-8.24 (2H, 
m, anthracenyl aromatic), 8.34 (IH, s, anthracenyl H10); c(90 MHz, CDC13) 22.14 
(CH2C(CH3)2), 25.27 (CH3 x 2), 31.13 (CH2CO hydrocinnamyl), 37.01 (CH 2-Ar 
hydrocinnamyl), 42.18 (CH2-Ar anthracenyl), 82.19 (C(CH3)2), 123.83, 124.65, 
125.44, 125.63, 126.07, 128.17, 128.33, 129.08 (aromatic), 129.27, 131.44, 133.82 
(anthracenyl quatemary), 140.43 (hydrocinnamyl quaternary), 172.22 (CO); m/z 
(FAB) 396 (M); HRMS: Found 396.20893. C 28H2802 requires 392.20892. 
Methvl-3-hvdroxvmethvloxetane (90 
1,1,1-Tris(hydroxymethyl)ethane (120 g, 1 mole) and diethyl carbonate (118 g, 1 
mole) and a solution of ethanolic potassium hydroxide (1 g in 10 ml) were heated at 
reflux under nitrogen for twenty minutes then approximately 2 moles of ethanol was 
distilled at atmospheric pressure. The remainder of the material was pyrolysed at a 
temperature of approximately 200-220°C and a pressure of 50-100 mmHg to 
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produce a distillate boiling between 120-140°C from which the title compound (35 g, 
34%) was then obtained by redistillation, b.p 40°C/22 mmHg (Lit. 96 , 80°C/40 
mmHg); vmax(CH2Cl2)/cm' 3621 (free OH), 3440 (H-bonded OH); H(200  MHz, 
CDC13) 1.12 (3H, s, CH3) 3.03 (1H, t, 3J 4.7 Hz, OH), 3.62 (2H, d, 3J 4.3 Hz, CH2 
(exo)), 4.34 (2H, d, 2J 5.8 Hz, CH2 (endo)), 4.48 (2H, 2J 5.8 Hz, CH2 (endo)). 
-Na-Benzyloxycarbonylaspar -tic acid-a-benzvI-3-3-methvl-3-hvdroxymethyloxetane 
ester (9 1 ) 
To a solution of NUbenzyloxylcarbonyIaspartic acid cx-benzyl ester (8.2 g, 23 
mmol) and 3-methyl-3-hydroxymethyloxetane (3 g, 30 mmol) in distilled 
dichloromethane (70 ml) stirred at 0°C was added dicyclohexylcarbodiimide (5.4 g, 
26 mmol) and a trace of DMAP. This was stirred for 2 days at 4°C, filtered and 
evaporated then dissolved in approximately 150 ml of ethyl acetate. This was washed 
with 10% sodium carbonate (2 x 100 ml), water (100 ml) and dried over MgSO4. 
Upon evaporation an oil was obtained and purified over silica gel eluted with 
chloroform and chloroform/methanol to yield the title compound (8.7g, 86%) as a 
clear oil, 1aID22  +13.90 (c 1.0, CHC1 3); TLC- Rf (A) 0.68, Rf (E) 0.24; 
vmar(CH2C12)/cm' 3432 (NH), 2960 and 2882 (CH), 1736 (ester CO), 1611 
(aromatic), 1508 (amide II); H(360  MHz, CDC13) 1.23 (3H, s, CH3), 2.93-3.07 (2H, 
m, 13CH2), 3.96-4.15 (2H, m, oxetane exo CH), 4.32-4.40 (4H, m, oxetane endo 
CH), 4.69 (1H, m, (xCH) 5.16, 5.18 (4H, s, CH2 benzylic), 6.0 (1H, d, NH), 7.33 
(10H, s, aromatic); 8C (50 MHz, CDC13) 20.64 (CH 3), 36.50 ([CH2), 38.68 (oxetane 
quaternary), 50.26 (aCH), 67.33 (oxetane exo CH 2) 66.80 and 68.75 (oxetane endo 
CH2), 79.05 (2 x benzylic CH 2), 127.79, 127.93, 128.14, 128.28 and 128.36 
(aromatic CH), 134.90 and 135.95 (aromatic quaternary), 155.79, 170.26 and 170.45 
(CO quaternary); m/z (FAB) 442 (MH); HRMS: Found 442.1870. C 24H28NO7 
requires 442.18656. 
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LB nzy IoxycarbonyI.2. ani i no-3-(4'-methyl-2 .6.7-trioxabicyclo[2.2.2]octyfl 
propionic acid (92) 
N-Benzyloxycarbonylaspartic acid-a-benzyl--3-methyl-3-hydrOxYmethYlOXetane 
ester (8.3 g, 18.8 mmol) was dissolved in freshly distilled dichioromethane (50 ml), 
cooled to 0°C and stirred under a stream of nitrogen. Freshly distilled boron 
trifluoride diethyl etherate (600 pi, 5 mmol) was added and the reaction stirred for 2 
hours at 0°C. The solution was concentrated then cooled and triethylamine (2.7 ml, 
20 mmol) was added. Ether was then added to precipitate the amine/Lewis acid 
complex. After filtration of this solid the solvent was removed in vaccuo then the 
title compound (6.6 g, 78%) was obtained by crystallisation from diethyl ether and 
washed with n-hexane, m.p. 98-100°C (Found C, 65.4; H, 6.2; N, 3.2. C24H27N07 
requires C, 65.3; H, 6.2; N, 3.2%); 1aI D22  -2.1° (c 3.0, CHC13); TLC- Rf (A) 0.81; 
Vm (CHC13)/cm 1  3429 (NH), 3032, 2939 and 2883 (CH), 1722 (ester CO), 1509 
(amide II); H(200  MHz, CDCI3) 0.72 (3H, s, CH3) 2.03-2.44 (211, m, CH2), 3.76 
(6H, s, ortho ester 3 x CH2), 4.50-4.54 (1H, m, aCH), 5.11 and 5.14 (4H, s, benzylic 
CH2), 6.08 (1H, d, NH), 7.34 (101-1, s, aromatic); c(50 MHz, CDC13) 14.07 (CH3), 
29.94 (ortho ester C-CH3 quaternary), 37.00 (3CH2), 50.13 (aCH), 66.59 (2 x 
benzylic CH2), 72.07 (ortho ester CH2), 107.81 (ortho ester C-O quaternary), 
127.84, 127.95, 128.06, 128.20 (aromatic CH), 135.54 and 135.89 (aromatic 
quaternary), 155.84. 170.18 and 171.04 (CO quaternary); m/z (FAB) 442 (MW); 
HRMS: Found 442.18659. C2 41128N07 requires 442.18656. 
2-Amino propionic pcid-3-methyl-2.6.7-trioxabicyclof2.2.2lOCtafle (93) 
propionic acid (3 g, 6.8 mmol) was dissolved in methanol (50 ml) and cooled to 0°C. 
Palladium on charcoal (10%, 300 mg) was added and the solution warmed to room 
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temperature. This was stirred under an atmosphere of hydrogen for 90 minutes. The 
catalyst was removed by filtration through celite and the solvent removed in vacuo. 
Trituration with ether produced the title compound (1.4 g, 95%) as a crystalline 
solid, m.p. 160°C (decomp.); TLC- R f (C) 0.13, Rf (B) 0.44; vm (KBr) 3376 
(broad), 1737 (carboxylate), 1268 (CO ortho ester); 5H(200 MHz, CD30D) 0.91 
(311, s, CH3), 2.05-2.55 (21-1, m, CH2), 3.85 (1H, d of d, 3J 11.2 Hz, 3J 2.4 Hz, 
aCH), 4.04 (6H, s, CH2 x 3); c(50 MHz, CD30D) 12.28 (CH3), 29.29 (quaternary 
CH3-0, 36.38 (CH2), 71.67 (CH 2 x 3), 106.91 (quaternary CH2C), 171.74 (CO); 
m/z (FAB) 218 (MH); HRMS: Found 218. 10285. C 9H 1 6N07 requires 218. 10284. 
Na9Fluorenylmethoxycarbonyh2 am i no .3.(4'. me thyI2.6.7 
trioxabicvclo[2.2.21octvl) propionic acid (94) 
A solution of 2-amino propionic acid-trioxabicycl[2.2.2]octane (400 mg, 1.8 mmol) 
in water (10 ml) containing triethylamine (260 .tI, 1.9 mmol) was stirred together 
with a solution of 9-fluorenylmethyl-succinimidyl carbonate (570 mg, 1.7 mmol) in 
dioxane (10 ml) for 4 hours. This was diluted with water (100 ml) then acidified 
with aqueous citric acid (20% w/v) and extracted with ethyl acetate (2 x 200 ml). 
The organic phase was washed with water (2 x 200 ml) and dried (MgSO4). A white 
foam was obtained upon evaporation which was crystallised from a solution of ether 
and n-hexane to give the title compound (500 mg, 67%), m.p. 88-92°C (Found: C, 
64.1; H, 6.6; N, 3.5. C241125N07 requires C, 65.6; H, 5.7; N, 3.2%); [a] D  -1.1 0 (c 
1.0, DMF); TLC- Rf (C) 0.65, R f (B) 0.8; max(CHC13)1nm 301, 290 (Idm 3mol 
1cm 1 4559, 3868); v m (CH2Cl2)/cm' 3432 (NH), 3054, 2986 (CH), 1730 (CO), 
1606 (aromatic), 1509 (amide 11), 1262 (CO. ortho ester); öH(200 MHz, CDC1 3) 
2.55-3.05 (311, s, C1I3), 2.55-3.05 (21-1, m, 3CH2), 3.49 (6H, s, CH2 x 3), 3.97-4.63 
(3H, m, Fmoc CH and Fmoc CH2), 6.35 (IH, d, NH), 7.20-7.78 (8H, m, aromatic); 
c(90 MHz, (CD 3)2S0); 16.64 (CH 3), 36.28 (CH2), 38.36(CCH3), 46.82 (Fmoc 
CH) 50.62 (aCH), 63.72 (3 x CH2), 66.81 (Fmoc CH 2), 120.34, 125.47, 127.33 and 
127.90 (aromatic), 140.94 and 144.00 (aromatic quaternary), 156.13 (ortho ester 
quaternary CO) 170.40 (urethane CO), 172.74 (acid CO); m/z (FAB) 440 (MW); 
HRMS: Found 440.17090. C24H26N07 requires 440.17091. 
Hvdrocinnamic acid 3-methyl-3-hydroxymethvloxetane ester 
Hydrocinnamic acid (3 g, 20 mmol) and 3-methyl-3-hydroxymethyloxetane (2 g, 
19.6 mmol) were dissolved in distilled dichloromethane and cooled to 0°C before the 
addition of DCC (4.1 g, 20 mmol) and DMAP (50 mg). After stirring for 2 days at 
4°C the solution was filtered and the solvent evaporated. The residue was dissolved 
in ethyl acetate (100 ml) and washed with sodium hydrogen carbonate (2 x 75 ml) 
and dried (MgSO4). The bulk of the solvent was removed in vacuo and then passed 
through a shallow pad of basic alumina which was washed with small 'portions of 
dichloromethane. The collected organic washings were evaporated to give the title 
compound (3.9 g, 85%) as a clear oil, TLC- Rf (E) 0.2, Rf (A) 0.79; 
vm (CH2Cl2)/cm' 3067, 3030, 2952 and 2882 (CH), 1736 (CO), 1602 (aromatic); 
8H(200 MHz, CDC13) 1.24 (3H, s, CH3), 2.62-2.71 (2H, m, CH2CH2CO), 2.91-2.99 
(2H, m, benzylic CH 2),4.12 (2H, s, oxetane CH exo), 4.30 (2H, d, 2J 6.0 Hz, oxetane 
CH endo), 4.42 (2H, d, 2J 5.9 Hz, oxetane CH endo) 7.12-7.3 1 (5H, m, aromatic); 
8c(90 MHz, CDC13) 20.80 (CH 3), 30.65 (CH2CO), 35.39 (benzylic CH2), 38.71 
(oxetane quatemary), 68.38 (CH2 exo), 79.20 (CH2 endo), 126.04 (aromatic C4), 
127.95 and 128.23 (aromatic CH), 139.99 (aromatic quaternary), 172.60 (CO); m/z 
(FAB) 235 (MW); HRMS: Found 235.13342. C 14H 1 903 requires 235.13341. 
Hydrocinnamvl-4-methyl-2.6.7-trioxabicyclo[2.2.2lOCtafle (98) 
Hydrocinnamic acid 3-methyl-3-hydroxymethyloxetane ester (3.5 g, 15 mmol) was 
dissolved in distilled dichioromethane and cooled to 0°C then distilled boron 
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trifluoride diethyl etherate (460 .tl, 3.75 mmol) was added and the solution 
maintained at 0°C for 3 hours. Triethylamine (2 ml,15 mmol) was added followed by 
ether (300 ml) and the precipitate filtered. Removal of the solvent in vacuo affords 
the title compound (2.5 g, 71%) as a white solid, m.p. 109-111°C; 
Vm (CH2C12)/cm 1 3055, 2971, 2937 and 2879 (CH), 1605 (aromatic), 1258 (CO 
stretch); H(200  M1-iz, CDC1 3) 0.81 (3H, s, CH 3 ), 1.95-2.06 (2H, m, CH2-CO), 
2.74-2.99 (2H, m, benzylic CH 2), 3.93 (6H, s, 3 x CH2 ortho ester), 7.13-7.32 (5H, 
m, aromatic); c(90 MHz, CDC13) 14.22 (CH3), 29.34 (CH2CO), 29.95 (CCH3), 
38.26 (benzylic CH 2), 72.31 (CH 2 x 3), 108.35 (CO), 125.48 (C4 aromatic), 128.1 
(CH aromatic) 141.61 (CO); m/z (FAB) 235 (MH); HRMS: Found 235.13342 
C14H 1903 requires 235.13341. 
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3.3 STABILITY STUDIES 
NMR Stability measurement 
Comparison of the acetate esters of dibenzosuberol and 4-nitrobenzyl alcohol 
Two solutions were prepared; 
A 4-nitrobenzyl acetate (51) (3.9 mg, 20.5 .imol) in hexadeuteroacetone (0.5 ml) 
B Dibenzosuberyl acetate (52) (5.0 mg, 20.5 j.tmol) in hexadeuteroacetone (0.5 ml) 
in standard NMR tubes. 
To each was added NaOH in D20 (0.2 ml, 0.125 M, 1 eq.) The NMR spectra were 
recorded at 200 MHz. The benzylic protons of (51) were used as diagnostic 8H 5.26 
(acetate) and 4.79 (alcohol). The 5-H resonance in (52) were used 8H 6.90 (acetate) 
and 6.17 (alcohol). Integration of these peaks provided a measure of the degree of 
hydrolysis. 
HPLC Stability measurement 
Using a C4 RP 300 Aquapore butyl 7 micron (4.6 x 100 mm) column with a gradient 





1-(9'-Anthracenyl)-3-methylbut-3-yl hydrocinnamate 	20.8 minutes 
9-Anthracenylmethyl hydrocinnamate 	 18.9 minutes 
Dibenzosuberyl hydrocinnamate 	 19.1 minutes 
Stability of hydrocinnamate esters to acidolysis 
To a solution of TFA in dichloromethane (10 ml) (20, 50 or 90%) was added the 
ester (20 mg). Over a period of time I ml portions were removed and evaporated 
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then dissolved in I ml of acetonitrile for HPLC analysis (25 tl injection) until 
acidolysis was complete. 
Stability of hydrocinnamate esters to alkaline hydrolysis 
The ester (2 mmol) was dissolved in dioxane (5 ml) then sodium hydroxide (4 
mmol) dissolved in water (5 ml) was added. Aliquots of 0.5 ml were removed at 
intervals and quenched using pH 7 phosphate buffer (25 ml) then 25 .tl injections 
were quantified using and automatic integrator attached to the HPLC detector. 
TLC Stability measurement 
Stability of 4-methyl-2,6,7-trioxabicyclo[2.2.2]octyl derivative 
N-benzyloxycarbonyl-2-amino-3-(4'-methyl-2,6,7-trioxabicyclo[2.2.2]OCtyl)-
propionic acid (20 mg) was dissolved with stirring in 95% aqueous trifluoroacetic 
acid (10 ml) and examined by TLC to monitor the progress of the reaction. Plates 
were run against a standard sample of startingmaterial and free acid and eluted with 
90% chloroform/10% methanol. 
Benzyloxycarbonyl aspartic acid benzyl ester R f 0.4. 
N-benzyloxycarbonyl-2-amino-3-(4'-methyl-2,6,7-trioxabiCyClO[2.2.2IoCtYl)-
propionic acid R f 0.68. 
Total hydrolysis of the ortho ester was observed within 1 minute. 
HIJ  
3.4 SOLID PHASE PEPTIDE SYNTHESIS 
Solid phase peptide synthesis was carried out on an Applied Biosystems 430A 
automated peptide synthesiser using standard cycles as summarised below; 
Removal of NaFmoc protecting group; 20% piperidinelDMF (9 ml), (3 min. and 
1 mm.). An aliquot is taken and diluted for UV monitoring (302 nm) to assess 
coupling efficiency. 
Washing of resin; DMF/dioxane (1:1), nine times. 
Activation of protected amino acid; First coupling Fmoc amino acid (1 mmol) in 
DMF/dioxane (6 ml, 2:1), with DIC (2 ml, 0.25 moldm 3 in dioxane) for 15 mm.. 
Second coupling Fmoc amino acid (0.5 mmol) in DMF (2 ml) with HOBt (2 ml, 
0.25 moldm 3 in dioxane) then DIC (2 ml, 0.25 moldm 3 in dioxane) for 20 mm.. 
Coupling of each activated species for 30 mm.. 
Washing of resin, 5 times between each coupling (DMF/dioxane, 1;1). 
Capping of unreacted amine functionality, A: 1 ml 0.5 moldm 3 acetic anhydride 
in DMF, 1 ml 0.5 moldm 3 pyridine in DMF then diluted with DMF (6 ml) for 3 
mm. then 6 mm.. B: 0.5 moldm 3 of acetic anhydride in DMF/0.125 moldm 3 of 
diisopropylethylamine in DMF/0.2% HOBt(w/v) in DMF,  10 ml of reagent for 10 
mm. 
Washing of resin DMF/dioxane (1:1)7 times. 
Val-Lys-Asp-Glv-Tyr-Ile 
This peptide was prepared using the cycles summarised except where otherwise 
indicated. Four syntheses were executed using Boc side chain protection for lysine, 
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tert-butyl protection for tyrosine and the protecting groups stated for aspartic acid; 
Fmoc-Ile-OH was dissolved in DMF with DIC (0.5 eq.) and a trace of DMAP to 
give the symmetrical anhydride and sonicated for 30 mm. with Wang resin (0.85 
mmol substitution). The resin was then filtered and washed with DMF, 
dichioromethane and ether. The loading is measured by U.V. 
9-Anthracenylmethyl 
0.55 mmol/g Fmoc-Ile-R. (456 mg, 0.25 mmol) was used as starting material for the 
synthesis. Standard double coupling was used with the exception of glycine which 
was coupled as it's symmetrical anhydride (2 eq.). The capping protocol used was A. 
1 -(4'-Fluorophenvl)-2-methvlprop-2-yI 
0.55 mmol/g Fmoc-lle-R (456 mg, 0.25 mmol) was used with coupling as 1 except 4 
equivalents of glycine symmetrical anhydride was used. Capping protocol A was 
used. 
1 -(9'-Anthracenvl)-2-methvlbut-2-vl 
0.39 mmol/g Fmoc-Ile-R (256 mg, 0.1 mmol) was used and the Fmoc amino acids 
were coupled as HOBt esters, double coupled (2 eq per coupling) and glycine as it's 
symmetrical anhydride (4 eq.).Capping protocol B was used. 
4'-Methyl-2.6.7-trioxabicvclo[2.2.2]octyl 
0.39 mmol/g Fmoc-Ile-R (256 mg, 0.1 mmol) used with the synthesis conditions as 
for 3. 
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Peptide cleavage conditions 
A. Aqueous TFA cleavage 
The peptide was liberated from the resin and the protecting groups removed in 
TFAlwater/anisole (93:4:0.3) for 3 hours. The resin was removed by flitration then 
the solvent removed in vacuo before trituration with ether. The ether was decanted 
and the peptide washed with ether dissolved in aqueous acetic acid (10 %) and 
lyophilised. Crude cleaved material was analysed by reversed phase HPLC with an 
integrator attached to calculate proportions of products. Purification for the purpose 
of characterisation was by reversed phase HPLC. (Vydac C 1 8 10 micron (25 x 250 
mm) Gradient: 5% B to 45% B (24 mm), 45% B to 95% B (26 mm), 95% B to 5% 
B (28 mm). 
I) 
TMSBrITFA cleavage 
A solution containing ethanedithiol (0.5 ml), m-cresol (0.1 ml), thioanisole (1.2 ml) 
and TFA (7.5 ml) was cooled to 0°C and the resin bound peptide added. 
Bromotrimethylsilane (1.3 ml) was added and the reaction stirred at 0°C for 15 
minutes under nitrogen. This was then partitioned between 20% acetic acid (v/v) and 
diethyl ether. The aqueous phase was then washed several times with ether and the 
lyophilised. 
Typical analytical data 
Peptide: 
HPLC: Vydac C 1 8 5 micron (4 x 250 mm) reverse phase column, R t 18.8 min.(5% 
B to 45% B (24 mm), 45% B to 95% B (26 mm), 95% B to 5% B (28 mm)); m/z 
(FAB) 694 (MH); HRMS: Found 694.37759. C32H 52N70 1 0 requires 694.37759; 
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Amino acid analysis, Val 0.99 (1.00); Lys 1.07 (1.00); Asp 1.10 (1.00), Gly 0.97 
(1.00); Tyr 0.85 (1.00), lie 0.95 (1.00). 
Aspartimide: 
HPLC: Vydac C 1 8 5 micron (4 x 250 mm) reverse phase column, R t 19.2 min.(5% 
B to 45% B (24 mm), 45% B to 95% B (26 mm), 95% B to 5% B (28 mm)); m/z 
(FAB) 676 (MH); HRMS: Found 676.36696 C 32H50N709 requires 676.36697; 
Amino acid analysis, Val 1.05 (1.00); Lys 0.97 (1.00); Asx 1.01(1.00), Gly 1.01 
(1.00); Tyr 0.93 (1.00), lie 1.02 (1.00). 
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